27 September 2022 | 17:45

Weekly update on the coronavirus SARS-CoV-2: 27 September 2022

Infections with the coronavirus SARS-CoV-2 in the Netherlands have been increasing for the past few weeks. Hospital admissions are also on the rise. More people are reporting symptoms which could indicate COVID-19. This may possibly be the start of the expected autumn wave of COVID-19. Vaccination and testing are very important in this phase to prevent the figures from rising sharply. 

Read the news: Autumn wave of COVID-19 may be starting: vaccination and testing are key 


27 September 2022 | 16:45 

First vaccination figures for autumn round of COVID-19 repeat vaccination

From this week on, RIVM will start posting updates on vaccination figures for the autumn round of the repeat vaccination against COVID-19. The autumn round started last week, on 19 September 2022. Up to and including Sunday 25 September, more than 261,500 repeat vaccinations had been administered in the autumn round. Most of the repeat vaccinations administered last week were in the age group of 80 years and older. Vaccination coverage for the repeat vaccination among people over 80 has now reached 11.9%.

Read more in the weekly update on COVID-19 vaccination figures.  

Archive COVID-19 weekly figures

20 September 2022 | 16:15

Weekly update on the coronavirus SARS-CoV-2: 20 September 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week increased again (+3.1%) compared to the week before that (+2.4%). The number of people who tested positive for COVID-19 (SARS-CoV-2) reported to the Municipal Public Health Services (GGDs) increased slightly (+6%) compared to the week before that. The number of people who were tested for COVID-19 by the GGD also increased slightly (+8%). On 6 September 2022, the reproduction number based on reported positive tests was 0.97 (0.91 – 1.04). The number of new hospital admissions of patients with SARS-CoV-2 was stable (-3%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low; there were 18 ICU admissions last week (+13%), compared to 16 ICU admissions the week before.

Sewage surveillance

In sewage surveillance, the national average viral load increased (+21.2%) in week 36 (5 – 11 September 2022), but decreased again (-22.6%) in the first half of week 37 (12 – 14 September). The regions that showed the biggest increase (Brabant-Noord) or the highest sewage surveillance figures (Gooi- en Vechtstreek, Brabant-Zuidoost) in week 36 also showed the biggest decrease in the first half of week 37. The BA.5 Omicron sub-variant is still observed most frequently in sewage surveillance. One sample was found to contain a Delta variant, and one sample contained the Omicron BA.2.75 variant.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variants BA.2.12.1 and BA.2.75), BA.3, BA.4 and BA.5. 

According to the WHO, these variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Sub-variant BA.5 became dominant in the Netherlands in June 2022. The percentage of these and other variants is being monitored in the context of pathogen surveillance and by means of variant PCR.

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany, Denmark and the UK, among other countries. BA.2.75 has been increasing recently in pathogen surveillance in the Netherlands. It is too early to say whether this will lead to an increase in the number of infections. BA.2.75 seems to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19 (by vaccination or previous infection). There are no indications that the BA.2.75 sub-variant would be more likely to cause severe illness compared to the other Omicron sub-variants. This sub-variant seems to be increasing slowly in the Netherlands and in the surrounding countries. RIVM will continue monitoring the situation.

Based on the latest pathogen surveillance data, trend forecasts for BA.2.75 suggest that this sub-variant may become dominant in the Netherlands later this year. However, the margins of uncertainty are still very significant. These trend forecasts are updated weekly based on new data from pathogen surveillance. 

     
Reports of people tested for SARS-CoV-2 who had a positive test result 13 September to 20 September1,2  6 September to 13 September3,4
Number of newly reported positive tests (by date as published by RIVM)

8,820

(49 per 100,000 inhabitants)

8,327

(46 per 100,000 inhabitants)

Hospital admissions by calendar week Week 371 Week 363

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

249

 

204

256

 

219

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

18

 

12

16

 

11

     
Reported deaths of people who tested positive for SARS-CoV-2 6 13 September to 20 September1,2 6 September to 13 September3,4
Deaths 10 11
SARS-CoV-2 tests by the GGD per calendar week week 377 week 367
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

12,358

7,152
57.9%

11,398

6,784
59.5%

  Latest calculation One week before
Reproduction numbers8 On 6 September 2022 On 30 August 2022
Based on reported positive tests 0,97 (0,91 – 1,04) 1,04 (0,96 – 1,11)
Based on hospital admissions (Source: NICE)9 0,95 (0,62 – 1,32) 1,02 (0,68 – 1,42)
Based on ICU admissions (Source: NICE)9 1,09 (0,00 – 3,16) 0,98 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 37 (12 to 14 September 2022) Week 35 (5 to 11 September 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 512 661
Number of sampling locations on which the average is based 297/31111 307/31112
Number of people connected to those sewage treatment plants13

16,718,306

16,961,366

1 As published 20 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 13 September 2022 10:01 and 20 September2022 10:00.

3As published 13 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 6 September 2022 10:01 and 13 September 2022  10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 20 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 19 September 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 311 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 


13 September 2022 | 15:55

Vaccination figures: 5 to 11 September 2022

The data flow between GGD-GHOR and RIVM is temporarily on hold. This is due to the preparations for data transfer related to the vaccinations in autumn 2022. Data publication is expected to resume in 1 to 2 weeks.


13 September 2022 | 15:50

Weekly update on the coronavirus SARS-CoV-2: 13 September 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week increased (+2.4%) compared to the week before that (+1.9%). The number of people who tested positive for COVID-19 (confirmed SARS-CoV-2 infection) reported to the Municipal Public Health Services (GGDs) increased slightly (+6%) compared to the week before that. The number of people who were tested for COVID-19 by the GGD increased slightly (+6%). On 30 August 2022, the reproduction number based on reported positive tests was 1.04 (0.96 – 1.11). The number of new hospital admissions of patients with SARS-CoV-2 increased (+16%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low; there were 16 ICU admissions last week (+7%), compared to 15 ICU admissions the week before.

Sewage surveillance

In sewage surveillance, the national average viral load in week 35 (29 August – 4 September 2022) increased slightly, rising by +4.4%. A significant increase was observed in Brabant-Zuidoost, which also saw the highest figures in sewage surveillance in that period. In the first half of week 36 (5 – 7 September), the average number of virus particles increased, rising by +29.1%. A significant increase was observed in Brabant-Noord, and the highest figures in sewage surveillance were seen in Gooi- en Vechtstreek. The BA.5 Omicron sub-variant is still observed most frequently, and various samples contained characteristic mutations that had previously been found in the Delta variant.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variants BA.2.12.1 and BA.2.75), BA.3, BA.4 and BA.5. 

According to the WHO, these variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Sub-variant BA.5 became dominant in the Netherlands in June 2022. The percentage of these and other variants is being monitored in the context of pathogen surveillance and by means of variant PCR.

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany, Denmark and the UK, among other countries. BA.2.75 has been increasing recently in pathogen surveillance in the Netherlands. It is too early to say whether this will lead to an increase in the number of infections. BA.2.75 seems to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19 (by vaccination or previous infection). There are no indications that the BA.2.75 sub-variant would be more likely to cause severe illness compared to the other Omicron sub-variants. This sub-variant seems to be increasing slowly in the Netherlands and in the surrounding countries. RIVM will continue monitoring the situation.

Based on the latest pathogen surveillance data, trend forecasts for BA.2.75 suggest that this sub-variant may become dominant in the Netherlands later this year. However, the margins of uncertainty are still very significant. These trend forecasts are updated weekly based on new data from pathogen surveillance. 

The increase in specific variants is also being monitored in cooperation with Saltro by means of variant PCR. Variant PCR data can be accessed a bit sooner than sequencing from pathogen surveillance. Variant PCR data offers an indication for whether the BA.4/5 sub-variants are present, although this method does not detect their presence with certainty. It also does not show the differences between BA.4 and BA.5. The data also offers an indication for whether BA.2.75 is present. The latest trend forecast indicates that BA.4/5 will decrease, accompanied by an increase in other variants, such as BA.2.75. The margins of uncertainty in this forecast are still significant. 

The data comes from various GGD regions, but (in contrast to pathogen surveillance data) the results do not provide a national overview. Pathogen surveillance data and variant PCR data show the same trends for the percentage of BA.4/BA.5. Saltro’s variant PCR data shows that the combined percentage of BA.4/BA.5 became dominant in early June.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 6 September to 13 September1,2  30  August to 6 September3,4
Number of newly reported positive tests (by date as published by RIVM)

8,327

(46 per 100,000 inhabitants)

7,856

(43 per 100,000 inhabitants)

Hospital admissions by calendar week Week 361 Week 353

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

256

 

219

220

 

179

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

16

 

11

15

 

10

     
Reported deaths of people who tested positive for SARS-CoV-2 6 6 September to 13 September1,2 30 August to 6 September3,4
Deaths 11 10
SARS-CoV-2 tests by the GGD per calendar week week 367 week 357
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

11,399

6,785
59.5%

10,731

6,409
59.7%

  Latest calculation One week before
Reproduction numbers8 On 30 August 2022 On 23 August 2022
Based on reported positive tests 1,04 (0,96 – 1,11) 0,95 (0,88 – 1,02)
Based on hospital admissions (Source: NICE)9 1,02 (0,68 – 1,42) 0,90 (0,58 – 1,26)
Based on ICU admissions (Source: NICE)9 0,98 (0,00 – 2,71) 0,86 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 36 (5 to 7 September 2022) Week 35 (29 August to 4 September 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 704 545
Number of sampling locations on which the average is based 284/31111 306/31112
Number of people connected to those sewage treatment plants13

15,511,930

16,996,439

1 As published 13 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 6 September 2022 10:01 and 13 September2022 10:00.

3As published 6 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 30 August 2022 10:01 and 6 September 2022  10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 13 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 12 September 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 311 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 

 


6 September 2022 | 16:00

Vaccination figures: 29 August to 4 September 2022

Up to and including Sunday 4 September, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,4%.

Read more in the weekly update on COVID-19 vaccination figures.  


6 September 2022 | 15:40

Weekly update on the coronavirus SARS-CoV-2: 6 September 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week increased slightly (+1.9%) compared to the week before that (+1.6%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) remained the same (+2%) compared to the week before that. The number of people who were tested for COVID-19 by the GGD remained the same (+3%). On 23 August 2022, the reproduction number based on reported positive tests was 0.95 (0.88 – 1.02). The number of new hospital admissions of patients with SARS-CoV-2 decreased ( 22%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low,  dropping to 15 ICU admissions last week (‑26%), compared to 20 ICU admissions the week before.

Sewage surveillance

In sewage surveillance, the national average viral load decreased slightly in week 34 (22 – 28 August 2022) and the first half of week 35 (29 – 31 August), dropping by ‑8.7% and ‑11.8% respectively. The average number of virus particles was highest in and around Amsterdam and The Hague in week 34, and in Brabant-Zuidoost in the first half of week 35 (based on preliminary figures). The BA.5 Omicron sub-variant is still observed most frequently.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variants BA.2.12.1 and BA.2.75), BA.3, BA.4 and BA.5. 

Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (>90% of the tested samples since week 29). According to the WHO, these variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany, Denmark and the UK, among other countries. BA.2.75 has been increasing recently in pathogen surveillance in the Netherlands. It is too early to say whether this will lead to an increase in the number of infections. BA.2.75 seems to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19 (by vaccination or previous infection). There are no indications that the BA.2.75 sub-variant would be more likely to cause severe illness compared to the other Omicron sub-variants. This sub-variant seems to be increasing slowly in the Netherlands and in the surrounding countries. RIVM will continue monitoring the situation.

Based on the latest pathogen surveillance data, trend forecasts for BA.2.75 suggest that this sub-variant may become dominant in the Netherlands in October 2022. However, the margins of uncertainty are still very significant. These trend forecasts are updated weekly based on new data from pathogen surveillance. The increase in specific variants is also being monitored in cooperation with Saltro by means of variant PCR. Variant PCR data can be accessed a bit sooner than sequencing from pathogen surveillance. Variant PCR data offers an indication for whether the BA.4/5 sub-variants are present, although this method does not detect their presence with certainty. It also does not show the differences between BA.4 and BA.5. The data also offers an indication for whether BA.2.75 is present. The latest trend forecast indicates that BA.4/5 will decrease, accompanied by an increase in other variants, such as BA.2.75. The margins of uncertainty in this forecast are still significant. The data comes from various GGD regions, but (in contrast to pathogen surveillance data) the results do not provide a national overview. Pathogen surveillance data and variant PCR data show the same trends for the percentage of BA.4/BA.5. Saltro’s variant PCR data shows that the combined percentage of BA.4/BA.5 became dominant in early June.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 30 August to 6 September1,2  23  August to 30 August3,4
Number of newly reported positive tests (by date as published by RIVM)

7,856

(43 per 100,000 inhabitants)

7,735

(42 per 100,000 inhabitants)

Hospital admissions by calendar week Week 351 Week 343

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

220

 

179

281

 

238

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

15

 

10

20

 

15

     
Reported deaths of people who tested positive for SARS-CoV-2 6 30 August to 6 September1,2 23 August to 30 August3,4
Deaths 10 12
SARS-CoV-2 tests by the GGD per calendar week week 357 week 347
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

10,731

6,409
59.7%

10,372

6,424
61.9%

  Latest calculation One week before
Reproduction numbers8 On 23 August 2022 On 15 August 2022
Based on reported positive tests 0,95 (0,88 – 1,02) 0,86 (0,81 – 0,92)
Based on hospital admissions (Source: NICE)9 0,90 (0,58 – 1,26) 0,82 (0,56 – 1,12)
Based on ICU admissions (Source: NICE)9 0,86 (0,00 – 2,71) 0,93 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 35 (29 to 31 August 2022) Week 34 (22 to 28 August 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 459 520
Number of sampling locations on which the average is based 288/31111 309/31112
Number of people connected to those sewage treatment plants13

15,953,267

17,095,520

1 As published 6 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 30 August 2022 10:01 and 6 September2022 10:00.

3As published 30 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 23 August 2022 10:01 and 30 August 2022  10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 6 September 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 5 September 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 311 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 

 

30 August 2022 | 16:20

Lower risk of hospital admission after COVID-19 booster jab or repeat vaccination

In the past 8 weeks, from 29 June to 23 August 2022, people aged 12 years and older who had the booster jab had a 51% lower risk of hospital admission than people who only received the basic series of COVID-19 vaccinations, which is a relative risk difference (RRD) of -51%. This means that the risk of hospital admission after a booster jab was about two times lower during this period, compared to people who only received the basic series of vaccinations. The risk of hospital admission for people aged 60 years and older who had the repeat vaccination against COVID-19 was 24% lower than for people who received the booster jab but not the repeat vaccination (RRD -24%). 

Read more on the webpage Lower risk of hospital admission after COVID-19 booster jab or repeat vaccination


30 August 2022 | 16:00

Vaccination figures: 22 to 28 August 2022

Up to and including Sunday 28 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54,2%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures. 


30 August 2022 | 15:40

Weekly update on the coronavirus SARS-CoV-2: 30 August 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week remained the same (1.6%) compared to the week before that (1.6%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased slightly (-11%) last week compared to the week before that. The number of people who were tested for COVID-19 by the GGD also decreased slightly (-17%). On 15 August 2022, the reproduction number based on reported positive tests was 0.86 (0.81 – 0.92). The number of new hospital admissions of patients with SARS-CoV-2 decreased slightly (-8%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low; there were 20 ICU admissions last week (-26%).

Sewage surveillance

In sewage surveillance, the national average viral load in week 33  (15 – 21 August 2022) remained about the same as in week 31. A similar trend was observed in the first half of week 34 (22 – 24 August). The average number of virus particles was highest in Amsterdam-Amstelland in week 33 and in Limburg-Noord in the first half of week 34. The BA.5 Omicron sub-variant is still observed most frequently.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variants BA.2.12.1 and BA.2.75), BA.3, BA.4 and BA.5. 

Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (>90% of the tested samples since week 29). According to the WHO, these variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany, Denmark and the UK, among other countries. BA.2.75 has been increasing recently in pathogen surveillance in the Netherlands. The next few weeks will show whether this upward trend will continue. It is too early to say whether this will lead to an increase in the number of infections. BA.2.75 seems to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19 (by vaccination or previous infection). There are no indications that the BA.2.75 sub-variant would be more likely to cause severe illness compared to the other Omicron sub-variants. This sub-variant seems to be increasing slowly in the Netherlands and in the surrounding countries. RIVM will continue monitoring the situation.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 23 August to 30 August1,2  16  August to 23 August3,4
Number of newly reported positive tests (by date as published by RIVM)

7,735

(42 per 100,000 inhabitants)

8,906

(48 per 100,000 inhabitants)

Hospital admissions by calendar week Week 341 Week 333

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

281

 

238

305

 

267

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

20

 

15

27

 

23

     
Reported deaths of people who tested positive for SARS-CoV-2 6 23 August to 30 August1,2 16 August to 23 August3,4
Deaths 12 31
SARS-CoV-2 tests by the GGD per calendar week week 347 week 337
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

10,372

6,423
61.9%

11,694

7,497
64.1%

  Latest calculation One week before
Reproduction numbers8 On 15 August 2022 On 8 August 2022
Based on reported positive tests 0,86 (0,81 – 0,92) 0,88 (0,83 – 0,93)
Based on hospital admissions (Source: NICE)9 0,82 (0,56 – 1,12) 0,89 (0,62 – 1,18)
Based on ICU admissions (Source: NICE)9 0,93 (0,00 – 2,71) 1,05 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 34 (22 to 24 August 2022) Week 33 (15 to 21 August 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 569 574
Number of sampling locations on which the average is based 298/31111 307/31112
Number of people connected to those sewage treatment plants13

16,478,607

17,006,836

1 As published 30 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 23 August 2022 10:01 and 30 August2022 10:00.

3As published 23 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 16 August 2022 10:01 and 23 August 2022  10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 30 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 29 August 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 311 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 


23 August 2022 | 16:00

Vaccination figures: 15 to 21 August 2022

Up to and including Sunday 21 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 54%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures.


23 August 2022 | 15:10

Weekly update on the coronavirus SARS-CoV-2: 23 August 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week decreased slightly (-1.6%) compared to the week before that (-1.9%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased (-24%) last week compared to the week before that. The number of people who were tested for COVID-19 by the GGD also decreased (-17%). On 8 August 2022, the reproduction number based on reported positive tests was 0.88 (0.83 – 0.93). The number of new hospital admissions of patients with SARS-CoV-2 remained the same compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 also remained stable and relatively low; there were 27 ICU admissions last week, compared to 26 ICU admissions the week before.

Sewage surveillance

In sewage surveillance, the national average viral load in week 32 (8 – 14 August 2022) decreased by 32.9% compared to week 31. In the first half of week 33 (15 – 17 July), the average number of virus particles increased slightly compared to the week before that, rising by 13.4%. In both weeks, the average number of virus particles was highest in Amsterdam-Amstelland. The BA.5 Omicron sub-variant was observed most frequently, while the BA.4 sub-variant was detected less often once again.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variants BA.2.12.1 and BA.2.75), BA.3, BA.4 and BA.5. 

Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (>90% of the tested samples since week 29). According to the WHO, these variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany and the UK, among other countries. This sub-variant has also been detected several times in pathogen surveillance in the Netherlands. Not much is known about BA.2.75 at this point. Like other Omicron sub-variants, BA.2.75 does seem to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19. For the time being, this sub-variant does not seem to be increasing rapidly or in the Netherlands or in the surrounding countries. RIVM will continue monitoring the situation.
 

     
Reports of people tested for SARS-CoV-2 who had a positive test result 16 August to 23 August1,2  9  August to 16 August3,4
Number of newly reported positive tests (by date as published by RIVM)

8,906

(48 per 100,000 inhabitants)

11,688

(63 per 100,000 inhabitants)

Hospital admissions by calendar week Week 331 Week 323

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

305

 

267

305

 

271

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

27

 

23

26

 

19

     
Reported deaths of people who tested positive for SARS-CoV-2 6 16 August to 23 August1,2 9 August to 16 August3,4
Deaths 31 25
SARS-CoV-2 tests by the GGD per calendar week week 337 week 327
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

11,694

7,497
64.1%

14,135

9,416
66.6%

  Latest calculation One week before
Reproduction numbers8 On 8 August 2022 On 1 August 2022
Based on reported positive tests 0,88 (0,83 – 0,93) 0,81 (0,77 – 0,85)
Based on hospital admissions (Source: NICE)9 0,89 (0,62 – 1,18) 0,79 (0,56 – 1,05)
Based on ICU admissions (Source: NICE)9 1,05 (0,00 – 2,71) 0,85 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 33 (15 to 17 August 2022) Week 32 (8 to 14 August 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 646 570
Number of sampling locations on which the average is based 293/31111 307/31112
Number of people connected to those sewage treatment plants13

16,322,045

17,195,457

1 As published 23 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 16 August 2022 10:01 and 23 August2022 10:00.

3As published 16 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 9 August 2022 10:01 and 16 August 2022  10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 23 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 22 August 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 311 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 


16 August 2022 | 17:15

Weekly update on the coronavirus SARS-CoV-2: 16 August 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week decreased (1.9%) compared to the week before that (2.4%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased (-21%) last week compared to the week before that. The number of people who were tested for COVID-19 by the GGD also continued to decrease (-27%). On 1 August 2022, the reproduction number based on reported positive tests was 0.81 (0.77 – 0.85). The number of new hospital admissions of patients with SARS-CoV-2 decreased (-31%) compared to the week before. Although the number of new ICU admissions of patients with SARS-CoV-2 remained relatively low, this figure rose from 23 to 26 (+13%) compared to the week before. 

Sewage surveillance

In sewage surveillance, the national average viral load in week 31 (1 – 7 August 2022) decreased by 24% compared to week 30. In sewage surveillance, the national average viral load in week 31 (1 – 7 August 2022) decreased by 24% compared to week 30. In the first half of week 32 (8 – 10 August), the average number of virus particles continued to decrease, dropping by 37%. The average number of virus particles was highest in Haaglanden in week 31 and in Amsterdam-Amstelland in week 32. The BA.5 Omicron sub-variant was observed most frequently, while the BA.4 sub-variant was detected less often once again.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. 

Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (>90% of the tested samples in week 30). According to the WHO, these new variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany and the UK, among other countries. This sub-variant has also been detected twice in pathogen surveillance in the Netherlands. Not much is known about BA.2.75 at this point. Like other Omicron sub-variants, BA.2.75 does seem to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19. For the time being, this sub-variant does not seem to be increasing rapidly or in the Netherlands or in the surrounding countries. RIVM will continue monitoring the situation.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 9 August to 16 August1,2  2  August to 9 August3,4
Number of newly reported positive tests (by date as published by RIVM)

11,688

(63 per 100,000 inhabitants)

14,878

(80 per 100,000 inhabitants)

Hospital admissions by calendar week Week 321 Week 313

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

305

 

271

445

 

396

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

26

 

19

23

 

18

     
Reported deaths of people who tested positive for SARS-CoV-2 6 9 August to 16 August1,2 2 August to 9 August3,4
Deaths 25 33
SARS-CoV-2 tests by the GGD per calendar week week 327 week 317
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

14,135

9,416
66.6%

19,366

12,982
67.0%

  Latest calculation One week before
Reproduction numbers8 On 1 August 2022 On 25 July 2022
Based on reported positive tests 0,81 (0,77 – 0,85) 0,81 (0,78 – 0,85)
Based on hospital admissions (Source: NICE)9 0,79 (0,56 – 1,05) 0,81 (0,60 – 1,04)
Based on ICU admissions (Source: NICE)9 0,85 (0,00 – 2,71) 0,89 (0,00 – 2,41)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 32 (8 to 10 August 2022) Week 31 (1 to 1 August 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 536 852
Number of sampling locations on which the average is based 288/31211 306/21212
Number of people connected to those sewage treatment plants13

15,981,929

17,048,636

16 August 2022 | 16:30

Vaccination figures: 8 to 14 August 2022

Up to and including Sunday 14 August, almost 2.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.7%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM.  

Read more in the weekly update on COVID-19 vaccination figures.


9 August 2022 | 16:00

Vaccination figures: 1 to 7 August 2022

Up to and including Sunday 7 August, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 53.2%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures.


9 August 2022 | 15:30

Weekly update on the coronavirus SARS-CoV-2:  9 August 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week remained reasonably stable (2.4%) compared to the week before that (2.7%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased (-31%) last week compared to the week before that. The number of people who were tested for COVID-19 by the GGD also decreased (-32%). On 25 July 2022, the reproduction number based on reported positive tests was 0.81 (0.78 – 0.85). The number of new hospital admissions of patients with SARS-CoV-2 decreased (-12%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low, and decreased (-18%) compared to the week before. 

Sewage surveillance

In sewage surveillance, the national average viral load in week 30 (25 ¬– 31 July 2022) decreased by 34% compared to week 29. In the first half of week 31 (1 – 3 August), the average number of virus particles continued to decrease, dropping by 19%. The average number of virus particles was highest in Gelderland-Zuid in week 30 and in Limburg-Noord in week 31. The BA.5 Omicron sub-variant was observed most frequently, while the BA.4 sub-variant was detected less often once again.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. 

Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (>90% of the tested samples in week 29). According to the WHO, these new variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Since July 2022, various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany and the UK, among other countries. This sub-variant has also been detected once in pathogen surveillance in the Netherlands. Not much is known about BA.2.75 at this point. Like other Omicron sub-variants, BA.2.75 does seem to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19. For the time being, this sub-variant does not seem to be increasing rapidly or in the Netherlands or in the surrounding countries. RIVM will continue monitoring the situation.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 2 August to 9 August1,2 26 July to 2 August3,4
Number of newly reported positive tests (by date as published by RIVM)

14,878

(80 per 100,000 inhabitants)

21,680

(119 per 100,000 inhabitants)

Hospital admissions by calendar week Week 311 Week 303

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

445

 

396

503

 

431

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

23

 

18

28

 

20

     
Reported deaths of people who tested positive for SARS-CoV-2 6 2 August to 9 August1,2 26 July to 2 August3,4
Deaths 33 25
SARS-CoV-2 tests by the GGD per calendar week week 317 week 307
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

19,366

12,983
67.0%

28,336

18,931
66.8%

  Latest calculation One week before
Reproduction numbers8 On 25 July 2022 On 18 July 2022
Based on reported positive tests 0,81 (0,78 – 0,85) 0,88 (0,84 – 0,91)
Based on hospital admissions (Source: NICE)9 0,81 (0,60 – 1,04) 0,83 (0,63 – 1,04)
Based on ICU admissions (Source: NICE)9 0,89 (0,00 – 2,41) 0,99 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 30 (1 to 3 August 2022) Week 30 (25 to 31 July 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 899 1108
Number of sampling locations on which the average is based 292/31211 306/21212
Number of people connected to those sewage treatment plants13

16,210,461

17,070,505

2 August 2022 | 17:50

New format for updates on COVID-19 hospital admissions based on vaccination status 

The monthly update on COVID-19 hospital admissions and vaccination status will have a different format as of 2 August 2022. From now on, it will compare the risk of hospital admissions between groups that have a different vaccination status.

Read more on the webpage New format for updates on COVID-19 hospital admissions based on vaccination status


2 August 2022 | 16:50

Weekly update on the coronavirus SARS-CoV-2:  2 August 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week remained stable (2.7%) compared to the week before that (2.7%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased (-23%) last week compared to the week before that. Reported infections also continued to decrease in nursing homes. The number of people who were tested for COVID-19 by the GGD decreased (-17%). On 18 July 2022, the reproduction number based on reported positive tests was 0.88 (0.84 – 0.91). The number of new hospital admissions of patients with SARS-CoV-2 decreased (-20%) compared to the week before. The number of new ICU admissions of patients with SARS-CoV-2 remained relatively low, and decreased (-35%) compared to the week before. Although the number of infections still seems fairly high, the downward trends indicate that the summer peak is behind us for now. 

Sewage surveillance

In sewage surveillance, the national average viral load in week 29 (18 – 24 July 2022) decreased by 10.0% compared to week 28. Viral loads were highest in and around Amsterdam, Rotterdam and The Hague. In the first half of week 30 (25 – 27 July), the average number of virus particles continued to decrease significantly, dropping by 33.6%. The BA.5 Omicron sub-variant was observed most frequently, while the BA.4 sub-variant was detected less often again.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. 

Many countries have recently seen an increase in sub-variant BA.5. The percentage of this variant is being monitored in the context of pathogen surveillance and by means of variant PCR. Since June 2022, Omicron BA.5 has been the dominant variant in the Netherlands (90% of the tested samples in week 38).

According to the WHO, these new variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 

Various countries have recently observed a new sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany and the UK, among other countries. This sub-variant has been detected once in pathogen surveillance in the Netherlands. Not much is known about BA.2.75 at this point. Like other Omicron sub-variants, BA.2.75 does seem to have minor specific mutations that enable it to more easily evade the immunity built up against COVID-19.  RIVM is monitoring the situation very closely.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 26 July to 2 August1,2 19 July to 26 July3,4
Number of newly reported positive tests (by date as published by RIVM)

21,680

(119 per 100,000 inhabitants)

28,019

(153 per 100,000 inhabitants)

Hospital admissions by calendar week Week 301 Week 293

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

503

 

431

631

 

534

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

28

 

20

43

 

27

     
Reported deaths of people who tested positive for SARS-CoV-2 6 26 July to 2 August1,2 19 July to 26 July3,4
Deaths 25 37
SARS-CoV-2 tests by the GGD per calendar week week 307 week 297
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

28,336

18,931
66.8%

33,950

23,858
70.3%

  Latest calculation One week before
Reproduction numbers8 On 18 July 2022 On 11 July 2022
Based on reported positive tests 0,88 (0,84 – 0,91) 0,84 (0,81 – 0,87)
Based on hospital admissions (Source: NICE)9 0,83 (0,63 – 1,04) 0,86 (0,67 – 1,06)
Based on ICU admissions (Source: NICE)9 0,99 (0,00 – 2,71) 0,92 (0,00 – 2,26)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 30 (25 to 27 July 2022) Week 29 (18 to 24 July 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 1115 1679
Number of sampling locations on which the average is based 295/31211 307/21212
Number of people connected to those sewage treatment plants13

16,375,721

17,057,534

1 As published 2 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 Reports by the Municipal Public Health Services (GGDs) to RIVM between 26 July2022 10:01 and 2 August2022 10:00.

3As published 26 July 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

Reports by the Municipal Public Health Services (GGDs) to RIVM between 19 July 2022 10:01 and 26 July 2022 10:00.

5Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

6 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

7 As published 2 August 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

8 For more information about the reproduction number, click here.

9 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

10 Based on data available at RIVM on Monday afternoon, 1 August 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

11 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

12 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.

13 Number of people connected to the number of sampling locations on which the average is based. 


2 August 2022 | 16:00

Vaccination figures: 25 to 31 July 2022

Up to and including Sunday 31 July, almost 2.6 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 52.2%.  Almost 70.000 repeat vaccinations have been administered in the past week. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures.

26 July 2022 | 16:15

Vaccination figures: 18 to 24 July 2022

Up to and including Sunday 24 July, more than 2.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 50.9%.  From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures.


26 July 2022 | 16:00

Weekly update on the coronavirus SARS-CoV-2:  26 July 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week (2.7%) decreased compared to the week before that (3.6%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased (-27%) last week compared to the week before that, and the number of people by the GGD also decreased (-33%). On 11 July 2022, the reproduction number based on reported positive tests was 0.84 (0.81 – 0.87). The decrease in tests and reported positive tests may possibly be due in part to the summer period, when many Dutch people are on holiday. However, there is also a decrease in the number of reported positive tests in nursing homes, a figure that is not expected to be affected by holidays (or hardly at all). Looking at hospital figures, the number of new hospital admissions of patients with SARS-CoV-2 decreased slightly, dropping by 12% compared to the week before, while the number of new patients with SARS-CoV-2 in the ICU remained relatively low (+8%) compared to the week before.

Sewage surveillance

In sewage surveillance, the national average viral load in week 28 (11 – 17 July 2022) rose by 17.8% compared to week 27. In the first half of week 29 (18 – 20 July), the average viral load decreased slightly, dropping by 6.8%. In both periods, viral loads were once again highest in and around Amsterdam and The Hague. The BA.5 Omicron sub-variant was observed most frequently in sewage in week 28, while the BA.4 sub-variant was detected less often again.

Virus variants from pathogen surveillance

More than 80% of all samples examined in week 27 (4 – 10 July) contained the BA.5 sub-variant. This variant became dominant in the Netherlands in June 2022. So far, the BA.2.75 sub-variant has only been found once during pathogen surveillance: in a sample taken in week 25 (20 – 26 June). 

     
Reports of people tested for SARS-CoV-2 who had a positive test result 19 July t/m 26 July1,2 12 July t/m 19 July3,4
Number of newly reported positive tests (by date as published by RIVM)

28,019

(153 per 100,000 inhabitants)

38,470

(212 per 100,000 inhabitants)

Hospital admissions by calendar week Week 291 Week 283

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

631

 

534

721

 

638

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

43

 

27

40

 

30

     
Reported deaths of people who tested positive for SARS-CoV-2 6 19 July t/m 26 July1,2 12 July t/m 19 July3,4
Deaths 37 30
SARS-CoV-2 tests by the GGD per calendar week week 297 week 287
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

33,949

23,857
70.3%

49,936

35,495
71.0%

  Latest calculation One week before
Reproduction numbers8 On 11 July 2022 On 4 July 2022
Based on reported positive tests 0,84 (0,81 – 0,87) 0,99 (0,96 – 1,03)
Based on hospital admissions (Source: NICE)9 0,86 (0,67 – 1,06) 0,97 (0,77 – 1,20)
Based on ICU admissions (Source: NICE)9 0,92 (0,00 – 2,26)) 0,98 (0,00 – 2,26)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 29 (18 to 20 July 2022) Week 28 (11 to 17 July 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 1740 1866
Number of sampling locations on which the average is based 293/31211 30721212
Number of people connected to those sewage treatment plants13

16,367,454

17,225,305

19 July 2022 | 16:00

Vaccination figures: 11 to 17 July 2022

Up to and including Sunday 17 July, more than 2.4 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 49.3%. Over 100,000 repeat vaccinations were administered last week. This is the highest number of repeat vaccinations in one week within the past three months. The strongest increase was seen among people in their 70s and 80s. Those age groups received twice as many repeat vaccinations last week compared to the week before that. From 8 July 2022 on, adults who have not yet had a booster jab or repeat vaccination against COVID-19 received a reminder letter from RIVM. 

Read more in the weekly update on COVID-19 vaccination figures.


19 July 2022 | 15:30

Weekly update on the coronavirus SARS-CoV-2:  19 July 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey, the percentage of people who reported possible symptoms of COVID-19 last week (3.6%) was comparable to the week before that (3.7%). The number of people who tested positive for COVID-19 reported to the Municipal Public Health Services (GGDs) decreased slightly (-11%) last week compared to the week before that. The number of people who were tested for COVID-19 also decreased slightly (-6%). On 4 July 2022, the reproduction number based on reported positive tests was 0.99 (0.96 – 1.03). However, the number of new hospital admissions of patients with SARS-CoV-2 increased 29% compared to the week before. Although the number of new ICU admissions of patients with SARS-CoV-2 remained relatively low and table (-7%) compared to the week before.  

Sewage surveillance

In sewage surveillance, the national average viral load in week 27 (4 – 10 July) remained about the same as in week 26, dropping only slightly (-2.8%). In the first half of week 28 (11 – 13 July), the average viral load increased again, rising by 14.6%. In both weeks, viral loads were once again highest in the metropolitan area, particularly in and around Amsterdam. The BA.5 Omicron sub-variant was observed most frequently in sewage in week 27. The BA.4 sub-variant was found to a much lesser extent, and the BA.2.12.1 sub-variant seems to be gradually disappearing.

Virus variants from pathogen surveillance

The percentage of the BA.5 sub-variant, which became dominant in June 2022, is still increasing. Various countries have recently observed a sub-variant of the Omicron BA.2 lineage: BA.2.75. This sub-variant has been found in India, Australia, Japan, Canada, the USA, Germany and the UK, among other countries. BA.2.75 has also been found in the Netherlands by now.

     
Reports of people tested for SARS-CoV-2 who had a positive test result 12 July t/m 19 July1,2 5 July t/m 12 July3,4
Number of newly reported positive tests (by date as published by RIVM)

38,470

(212 per 100,000 inhabitants)

43,220

(2242per 100,000 inhabitants)

Hospital admissions by calendar week Week 281 Week 273

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

721

 

638

561

 

495

Total new ICU admissions of patients with SARS-CoV-2

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)5

40

 

30

43

 

35

     
Reported deaths of people who tested positive for SARS-CoV-2 6 12 July t/m 19 July1,2 5 July t/m 12 July3,4
Deaths 30 17
SARS-CoV-2 tests by the GGD per calendar week week 287 week 277
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

49,938

35,497
71.1%

52,916

7,869
71.6%

  Latest calculation One week before
Reproduction numbers8 On 4 July 2022 On 27 June 2022
Based on reported positive tests 0.99 (0.96 – 1.03) 1.01 (0.97 – 1.05)
Based on hospital admissions (Source: NICE)9 0.97 (0.77 – 1.20) 0.96 (0.75 – 1.19)
Based on ICU admissions (Source: NICE)9 0.98 (0.00 – 2.26) 1.11 (0.00 – 2.71))
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 28 (11 to 13 July 2022) Week 27 (4 to 11 July 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)10 1795 1567
Number of sampling locations on which the average is based 287/31211 310/21212
Number of people connected to those sewage treatment plants13

16,444,664

17,306,272

12 July 2022 | 16:00

Vaccination figures: 4 to 10 July 2022

Up to and including Sunday 10 July, more than 2.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.3%. 

Read more in the weekly update on COVID-19 vaccination figures.


12 July 2022 | 15:50

Weekly update on the coronavirus SARS-CoV-2:  12 July 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. 

Read more on the webpage Weekly coronavirus SARS-CoV-2 figures.


5 July 2022 | 16:15

COVID-19 booster jab and repeat vaccination needed for older people to restore protection

In the period from 15 March 2022 to 28 June 2022, hardly any protection against hospital and ICU admission could still be detected from the basic series of COVID-19 vaccinations. This is because the vast majority of people who only received the basic series were vaccinated nearly a year ago by now, and vaccinations (and previous infections) provide protection against hospital admission which diminishes over time.

Read more: COVID-19 booster jab and repeat vaccination needed for older people to restore protection


5 July 2022 | 16:00

Vaccination figures: 27 June – 3 July 2022

Up to and including Sunday 3 July, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 47.1%. For the past 3 weeks, the weekly number of repeat vaccinations has been increasing. More than twice as many repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen among people aged 60-69 years. 

Read more in the weekly update on COVID-19 vaccination figures.


5 July 2022 | 15:30

Weekly update on the coronavirus SARS-CoV-2:  5 July 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. For more background information see the news: SARS-CoV-2 infections rising less rapidly.

28 June 2022 | 16:50

Weekly update on the coronavirus SARS-CoV-2:  28 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. For more background information see the news: SARS-CoV-2 infections continue to rise.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 stabilised at about 3.5%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased (+29%) last week compared to the week before that. This increase was observed in all age groups and in all security regions. On 13 June 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 increased 7%, while the number of new patients with SARS-CoV-2 in the ICU rose 10%, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of 49.2% was observed in the national average number of virus particles in week 24 compared to week 23. Once again, viral loads were highest in the metropolitan area, particularly in and around Amsterdam. In the first half of week 25, the average number of virus particles continued to increase, rising by 30.3%; at that time, those levels were particularly high in and around The Hague. The Omicron sub-variant BA.2 is still present in sewage, but the BA.5 Omicron sub-variant was observed most frequently in week 24. The BA.4 sub-variant was found to a lesser extent, and the BA.2.12.1 sub-variant continued to decrease significantly.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. Many countries have recently seen an increase in sub-variants BA.4 and BA.5. BA.2.12.1 is also increasing in some countries. The data from pathogen surveillance shows that BA.5 became dominant in the Netherlands in June 2022. Saltro’s variant PCR data shows the same trend. 

According to the WHO, these new variants do not appear to cause more serious illness than the BA.2 variant that was recently most prevalent in the Netherlands. However, there are indications that antibodies may be less effective against these variants. 
 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

34,1451

(192 per 100,000 inhabitants)

26.4622

(149 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

437

 

374

408

 

337

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

32

 

21

29

 

25

Deaths5 15 11
     
SARS-CoV-2 tests by the GGD per calendar week6 week 25 week 24
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

42,247

29,571
70.0%

32,042

21,856
68.2%

  Latest calculation One week before
Reproduction numbers7 On 13 June 2022 On 6 juni 2022
Based on reported positive tests 1,16 (1,10 – 1,22) 1,25 (1,17 – 1,34)
Based on hospital admissions (Source: NICE)8 1,06 (0,77 – 1,37) 1,01 (0,68 – 1,38)
Based on ICU admissions (Source: NICE)8 1,10 (0,00 – 2,71) 1,14 (0,00 – 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 25 (20 to 22 June 2022) Week 24 (13 to 19 June 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 1256 964
Number of sampling locations on which the average is based 298 / 31210 308 / 31211
Number of people connected to those sewage treatment plants12

16,668,672

17,215,260

 GGD reports to RIVM between 21 June 2022 10:01 and 28June 2022 10:00 as published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 GGD reports to RIVM between 14 June 2022 10:01 and 21 June 2022 10:00 as published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

3 As published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.

4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

6 As published 28 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

7 For more information about the reproduction number, click here.

8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

9 Based on data available at RIVM on Monday afternoon, 27 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.

12 Number of people connected to the number of sampling locations on which the average is based.
 


28 June 2022 | 16:30

Vaccination figures: 20 June – 26 June 2022

Up to and including Sunday 26 June 2022, more than 2.2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their booster jab or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 45.7%. For the past two weeks, the weekly number of repeat vaccinations has been increasing. 59% more repeat vaccinations were administered last week compared to the week of 6 June. The strongest increase was seen in the age group of people aged 60 to 70 years. 

Read more in the weekly update on COVID-19 vaccination figures. 


 21 June 2022 | 16:30

Weekly update on the coronavirus SARS-CoV-2:  21 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance. 

For more information read the news: Upward trend in infections continues

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 continued rising to above 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased significantly (+70%) last week compared to the week before that. This increase was observed in all age groups and in all security regions. On 6 June 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 stabilised, but the number of new patients with SARS-CoV-2 in the ICU rose by 37%, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of 37.6% was observed in the national average number of virus particles in week 23 compared to week 22. As in last week’s update, the average number of virus particles was particularly high in and around Amsterdam and The Hague. In the first half of week 24, the average number of virus particles continued to increase, rising by 34.1%. The Omicron sub-variant BA.2 is still very present in sewage, but a significant increase in the number of sewage samples containing mutations specifically associated with BA.5 was observed again in week 23. The BA.4 mutations were found to a lesser extent, and there was a significant decrease in the mutations specific to BA.2.12.1.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. Many countries have recently seen an increase in sub-variants BA.4 and BA.5. BA.2.12.1 is also increasing in some countries. Based on the latest pathogen surveillance data, trend forecasts for Omicron sub-variants BA.4, BA.5 and BA.2.12.1 suggest that BA.5 will become dominant. Saltro’s variant PCR data shows a comparable trend, indicating that the combined percentage of BA.4/BA.5 became dominant in early June. 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

26,4621

(149 per 100,000 inhabitants)

15,5262

(87 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

312

 

268

311

 

258

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

26

 

22

19

 

16

Deaths5 11 10
     
SARS-CoV-2 tests by the GGD per calendar week6 week 24 week 23
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

32,042

21,856
68.2%

18,241

11,938
65.4%

  Latest calculation One week before
Reproduction numbers7 On 6 June 2022 On 30 May 2022
Based on reported positive tests 1,25 (1,17 – 1,22) 1,13 (1,04 – 1,22)
Based on hospital admissions (Source: NICE)8 1,01 (0,68 – 1,38) 0,99 (0,60 – 1,45)
Based on ICU admissions (Source: NICE)8 1,14 (0,00 – 2,71) 1,14 (0,00 – 3,16)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 24 (13 to 15 June 2022) Week 23 (6 to 12 June 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 868 647
Number of sampling locations on which the average is based 299 / 31210 306 / 31211
Number of people connected to those sewage treatment plants12

16,778,050

17,137,783

 1 GGD reports to RIVM between 14 June 2022 10:01 and 21 June 2022 10:00 as published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

2 GGD reports to RIVM between 7 June 2022 10:01 and 14 June 2022 10:00 as published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

3 As published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.

4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.

5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.

6 As published 21 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.

7 For more information about the reproduction number, click here.

8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.

9 Based on data available at RIVM on Monday afternoon, 20 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.

10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.

11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.

12 Number of people connected to the number of sampling locations on which the average is based.


21 June 2022 | 16:00

Vaccination figures: 13 June – 19 June 2022

Up to and including Sunday 19 June 2022, more than 2.1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 44.2%.

Read more in the weekly update on COVID-19 vaccination figures. 


14 June 2022 | 19:30

Weekly update on the coronavirus SARS-CoV-2:  14 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

More information : read the news Many more infections, limited increase in hospital admissions

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week,the percentage of people who reported possible symptoms of COVID-19 continued to increase, rising to over 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased significantly (+64%) last week compared to the week before that. This increase was observed in all age groups and security regions. On 30 May 2022, the reproduction number based on reported positive tests was above 1. The number of new hospital admissions of patients with SARS-CoV-2 increased by 12% and the number of new patients with SARS-CoV-2 in the ICU remained the same, compared to the week before.

Sewage surveillance

In sewage surveillance, an increase of +62.4% was observed in the national average number of virus particles in week 22 compared to week 21. The average number of virus particles was particularly high in and around Amsterdam and The Hague, In the first half of week 22, the average number of virus particles continued to increase, rising by +37,3%. The Omicron sub-variant BA.2 is still very present in sewage, but from week 20 on, there was a significant increase in the number of sewage samples containing mutations specifically associated with BA.4, BA.5 and BA.2.12.1. In weeks 21 and 22, the upward trend seemed to continue in particular for the specific mutations associated with sub-variant BA.5.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2 (including sub-variant BA.2.12.1), BA.3, BA.4 and BA.5. However, it is currently very unclear which Omicron sub-variant is spreading fastest and will become dominant. Based on the latest pathogen surveillance data and the variant PCR data, there has been an increase in BA.4 and BA.4; the variant PCR provides slightly more up-to-date data. Based on this variant PCR data, these two sub-variants represented over half of total numbers by the end of last week. In addition to BA.4 and BA.5, pathogen surveillance also shows an increase in a BA.2 sub-variant, BA.2.12.1.

1 GGD reports to RIVM between 7 June 2022 10:01 and 14 June 2022 10:00 as published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
2 GGD reports to RIVM between 31 May 2022 10:01 and 7 June 2022 10:00 as published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
3 As published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
6 As published 14 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
7 For more information about the reproduction number, click here.
8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 13 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
12 Number of people connected to the number of sampling locations on which the average is based.


14 June 2022 | 16:00

Vaccination figures: 6 June – 12 June 2022

Up to and including Sunday 12 June 2022, more than 2 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 43.1%.

See:  Archive COVID-19 vaccination figures 2022


7 June 2022 | 15:40 PM

Weekly update on the coronavirus SARS-CoV-2:  7 June 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital admissions, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, the percentage of people who reported possible symptoms of COVID-19 rose from about 2% to about 3%. The number of people who were tested for COVID-19 and the number of newly reported positive COVID-19 tests increased (+33%) last week compared to the week before that. This increase was observed in all age groups, except among children aged 0-12 years, and the largest increase was among people aged 13-29 years. On 19 May 2022, the reproduction number based on reported positive tests was around 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 23% and the number of new patients with SARS-CoV-2 in the ICU stabilised, compared to the week before.

Sewage surveillance

In sewage surveillance, a slight decrease of -8.7% was observed in the national average number of virus particles in week 21 compared to week 20. In the first two days of week 22, the average number of virus particles increased slightly again, rising by +7.8%. Sewage surveillance figures seem to have plateaued for the time being. However, the average number of virus particles in and around the major cities (Amsterdam, Rotterdam, The Hague) is high compared to the rest of the Netherlands. The Omicron sub-variant BA.2 is still very present in sewage, but in week 20, there was a significant increase in the number of sewage samples containing mutations specifically associated with BA.4, BA.5 and BA.2.12.1. In week 21, the upward trend seemed to continue in particular for the specific mutations associated with sub-variants BA.5 and BA.2.12.1.

Virus variants from pathogen surveillance

So far, the Omicron variant has five sub-variants that are currently being monitored closely. These have been designated BA.1, BA.2, BA.3, BA.4 and BA.5. The BA.2 sub-variant is currently dominant in the Netherlands. The percentage of sub-variants BA.4, BA.5 and BA.2.12.1, a sub-variant of BA.2, is increasing in pathogen surveillance. However, it is currently very unclear which Omicron sub-variant is spreading fastest and will become dominant.   BA.4 and BA.5 differ in some respects, but have the same changes in the spike protein, and are therefore likely to have very similar properties. BA.2.12.1 has another change in the spike protein. There is currently no reason to believe that any of these sub-variants would cause a more severe course of disease. 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

9,4591

(53 per 100,000 inhabitants)

7,0882

(39 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

128

 

108

167

 

140

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

14

 

13

14

 

8

Deaths5 3 13
     
SARS-CoV-2 tests by the GGD per calendar week6 week 22 week 21
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

13.084

7.782
59,5%

9.992

5.288
52,9%

  Latest calculation One week before
Reproduction numbers7 On 19 May 2022 On 16 May 2022
Based on reported positive tests 0,99 (0,91 - 1,07) 0,89 (0,82 - 0,95)
Based on hospital admissions (Source: NICE)8 0,88 (0,49 - 1,35) 0,80 (0,43 - 1,22)
Based on ICU admissions (Source: NICE)8 1,08 (0,00 - 3,31) 0,83 (0,00 - 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 22 (30 to 31 May 2022) Week 21 (23 to 29 May 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 301 279
Number of sampling locations on which the average is based 236 / 31210 305 / 31211
Number of people connected to those sewage treatment plants12 14,151,238 17,037,272

1 GGD reports to RIVM between 31 May 2022 10:01 and 7 June 2022 10:00 as published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
2 GGD reports to RIVM between 24 May 2022 10:01 and 31 May 2022 10:00 as published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
3 As published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
6 As published 7 June 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
7 For more information about the reproduction number, click here.
8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 6 June 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
12 Number of people connected to the number of sampling locations on which the average is based.

31 May 2022 | 16:10 PM

Weekly update on the coronavirus SARS-CoV-2:  31 May 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital occupancy, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, , there was a stabilisation in the percentage of people who reported possible symptoms of COVID-19. . The number of newly reported positive COVID-19 tests recorded by the Municipal Public Health Services (GGDs) decreased slightly (-5%) last week compared to the week before that. The reproduction number is below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 31% and the number of new patients with SARS-CoV-2 in the ICU decreased by 22%, compared to the week before.

Sewage surveillance

In sewage surveillance, a very slight increase of +3.5% was observed in the national average number of virus particles in week 20 compared to week 19. In the first half of week 21, the average number of virus particles decreased slightly again, dropping by -3.6%; sewage surveillance figures seem to have plateaued. In weeks 18 and 19, an increasing number of sewage samples were found to contain mutations associated with the Omicron sub-variants BA.4, BA.5 and BA.2.12.1. In week 20, there was a significant increase in the number of sewage samples containing specific mutations associated with BA.4, BA.5 and BA.2.12.1. At five sampling locations, BA.5 was the most common variant in the sewage sample.

Virus variants from pathogen surveillance

A continued increase in BA.4 and BA.5 has been observed in recent weeks in the context of pathogen surveillance.  

Based on pathogen surveillance, trend forecasts for these sub-variants suggest that they may become dominant in June 2022. The increase in BA.4 and BA.5 is also being monitored in cooperation with Saltro by means of variant PCR. Variant PCR data can be accessed sooner and offers an indication for whether the BA.4/5 sub-variants are present, although this method does not detect their presence with certainty; sequencing is performed to confirm which variant is involved.  Trend forecasts for BA.4 and BA.5 based on this more recent variant PCR data suggest that these sub-variants may become dominant as soon as early June 2022. However, the margins of uncertainty are still significant.  

Some countries have observed an increase in a BA.2 sub-variant, designated BA.2.12.1. This sub-variant is also increasing in pathogen surveillance, but has not been included in the current forecast. This sub-variant cannot be distinguished from BA.2 based on Saltro’s variant PCR data. Which Omicron sub-variant is spreading fastest is currently unclear. 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

7,0881

(39 per 100,000 inhabitants)

7,4562

(41 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

154

 

126

223

 

174

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

14

 

8

18

 

13

Deaths5 13 12
     
SARS-CoV-2 tests by the GGD per calendar week6 week 21 week 20
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

9,990

5,286
52.9%

11,728

6,041
51,5%

  Latest calculation One week before
Reproduction numbers7 On 16 May 2022 On 9 May 2022
Based on reported positive tests 0,89 (0,82 - 0,95) 0,88 (0,83 - 0,93)
Based on hospital admissions (Source: NICE)8 0,80 (0,43 - 1,22) 0,85 (0,51 - 1,25)
Based on ICU admissions (Source: NICE)8 0,83 (0,00 - 2,71) 0,92 (0,00 - 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 21 (23 to 25 May 2022) Week 20 (16 to 22 May 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 295 306
Number of sampling locations on which the average is based 230 / 31210 307 / 31211
Number of people connected to those sewage treatment plants12 14,706,501 17,130,180

1 GGD reports to RIVM between 24 May 2022 10:01 and 31 May 2022 10:00 as published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
2 GGD reports to RIVM between 17 May 2022 10:01 and 24 May 2022 10:00 as published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
3 As published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
6 As published 31 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
7 For more information about the reproduction number, click here.
8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 30 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
12 Number of people connected to the number of sampling locations on which the average is based.


31 May 2022 | 16:00

Vaccination figures: 23 to 29 May 2022

Up to and including Sunday 29 May, more than 2 million repeat vaccinations had been administered in the Netherlands. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 41.8%.

See:  Archive COVID-19 vaccination figures 2022


24 May 2022 | 15:30 PM

Weekly update on the coronavirus SARS-CoV-2:  24 May 2022

As of 17 May 2022, expanded information about the coronavirus SARS-CoV-2 is provided on this page. In addition to figures on positive tests and hospital occupancy, the page also includes information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, , there was a stabilisation in the percentage of people who reported possible symptoms of COVID-19. The number of newly reported positive COVID-19 tests decreased (-11%) last week compared to the week before that. The reproduction number is below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 18% and the number of new patients with SARS-CoV-2 in the ICU stabilised, compared to the week before.

Sewage surveillance

In sewage surveillance, a decrease of 15.7% was observed in the national average viral load in week 19 compared to week 18. In the first half of week 20, the average viral load continued to decrease slightly, dropping 6.3%. Omicron variant BA.2 had been the main variant found in the sewage samples in the past few weeks. In weeks 18 and 19, an increasing number of samples were found to contain shared BA.4/BA.5 mutations, as well as more specific mutations associated with BA.4 and BA.5. BA.2.12.1 was also detected in more samples.

Virus variants from pathogen surveillance

An increase in BA.4 and BA.5 has been observed in recent weeks in the context of pathogen surveillance. Trend forecasts for these sub-variants suggests that they may become dominant in July 2022. However, the margins of uncertainty are still very significant. Since BA.4 and BA.5 are currently only showing up in low numbers in pathogen surveillance, it is not yet possible to predict which of these two sub-variants will become dominant. For that reason, the current forecast displays these two together as BA.4/BA.5.  

Some countries have observed an increase in a BA.2 sub-variant, designated BA.2.12.1. This sub-variant has also been detected in pathogen surveillance, but has not been included in the current forecast. Which sub-variant is spreading fastest is currently unclear.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

7,4561

(41 per 100,000 inhabitants)

8,3722

(46 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

197

 

158

241

 

193

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

18

 

12

18

 

12

Deaths5 12 16
     
SARS-CoV-2 tests by the GGD per calendar week6 week 20 week 19
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

11,729

6,042
51.5%

13,151

6,922
52,6%

  Latest calculation One week before
Reproduction numbers7 On 9 May 2022 On 2 May 2022
Based on reported positive tests 0,88 (0,83 - 0,93) 0,89 (0,85 - 0,94)
Based on hospital admissions (Source: NICE)8 0,85 (0,51 - 1,25) 0,79 (0,49 - 1,14)
Based on ICU admissions (Source: NICE)8 0,92 (0,00 - 2,71) 0,81 (0,00 - 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 20 (16 to 18 May 2022) Week 19 (9 to 15 May 2022)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 277 296
Number of sampling locations on which the average is based 268 / 31210 311 / 31211
Number of people connected to those sewage treatment plants12 14,993,916 17,339,858

1 GGD reports to RIVM between 17 May 2022 10:01 and 24 May 2022 10:00 as published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
2 GGD reports to RIVM between 10 May 2022 10:01 and 17 May 2022 10:00 as published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
3 As published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
6 As published 24 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
7 For more information about the reproduction number, click here.
8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 23 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
12 Number of people connected to the number of sampling locations on which the average is based.


17 May 2022 | 16:15

Vaccination figures: 9 to 15 May 2022

Up to and including Sunday 15 May, more than 1.9 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 39.9%.

Read more in the weekly update on COVID-19 vaccination figures.


17 May 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  17 May 2022

As of today (17 May 2022), we are expanding the information on this page about the coronavirus SARS-CoV-2. In addition to figures on positive tests and hospital occupancy, we will also be adding information from the Infection Radar surveys, sewage surveillance and pathogen surveillance.

Infection Radar, testing, and hospital and ICU admissions

In the Infection Radar survey last week, there was a drop in the percentage of people who reported possible symptoms of COVID-19. The number of newly reported positive COVID-19 tests decreased (16%) last week compared to the week before that. The reproduction number is also below 1. The number of new hospital admissions of patients with SARS-CoV-2 decreased by 31% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 26%, compared to the week before.

Sewage surveillance

In week 18, the national average for virus particles in sewage increased slightly, rising by 7.1% compared to week 17. In the first half of week 19, the average number of virus particles decreased by 21.0%.

Omicron variant BA.2 was the main variant found in the sewage samples. Looking at the sub-variants of BA.2, samples primarily contained the sub-variant BA.2.9, to a lesser extent BA.2.3 and in a few cases BA.2.12. The number of sewage samples with BA.4/BA.5 mutations increased this week compared to last week.

Virus variants from pathogen surveillance

In recent weeks, Omicron variant BA.2 has been the most prevalent. This variant was found in 98% of all samples sequenced in weeks 16 and 17. Omicron BA.4 was detected 3 times: in weeks 14, 15 and 16. Omicron BA.5 was detected once in week 16 and twice in week 17.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

8,3721

(46 per 100,000 inhabitants)

10,0072

(55 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

215

 

172

311

 

252

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

17

 

11

23

 

19

Deaths5 16 19
     
SARS-CoV-2 tests by the GGD per calendar week6 week 19 week 18
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

13,152

6,923
52.6%

15,465

8,248
53,3%

  Latest calculation One week before
Reproduction numbers7 On 2 May 2022 On 25 April 2022
Based on reported positive tests 0,89 (0,85 - 0,94) 0,95 (0,90 - 1,00)
Based on hospital admissions (Source: NICE)8 0,79 (0,49 - 1,14) 0,78 (0,49 - 1,11)
Based on ICU admissions (Source: NICE)8 0,81 (0,00 - 2,71) 0,82 (0,00 - 2,71)
  Last week (first half of the week) Two weeks ago (first and second half of the week)
Sewage surveillance Week 19 (9 to 11 May) Week 18 (2 to 8 May)
Average number of virus particles (x 100 billion per 100,000 inhabitants)9 273 345
Number of sampling locations on which the average is based 233 / 31210 310 / 31211
Number of people connected to those sewage treatment plants12 13,401,926

17,192,117

1 Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission. Current figures on hospital admissions of patients with SARS-CoV-2 categorised by admission reason can be viewed on the RIVM graphs page, or in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
1 GGD reports to RIVM between 10 May 2022 10:01 and 17 May 2022 10:00 as published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
2 GGD reports to RIVM between 3 May 2022 10:01 and 10 May 2022 10:00 as published 10 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
3 As published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures may be updated to include any registrations provided later by the NICE Foundation, especially regarding the past week and the week before that.
4Not all patients admitted to hospital with the coronavirus SARS-CoV-2 have COVID-19 as the main reason or one of the reasons for hospital admission.  The hospital and ICU admissions for which it is known that admission was due to other reasons than a SARS-CoV-2 infection (category 3 in the admission reasons) are not counted here. For an explanation of the categories of admission reasons, see the RIVM graphs page, or the weekly epidemiological update on SARS-CoV-2 in the Netherlands.
5 Not all of these reported deaths occurred within the last week. The actual number of deaths is higher than the deaths that are reported in the surveillance. This is because there is no mandatory reporting requirement for death due to COVID-19. For that reason, the mortality figures presented here are underreported.
6 As published 17 May 2022 in the weekly epidemiological update on SARS-CoV-2 in the Netherlands. The figures from the past week and current week may be updated to include any test results provided later. These figures only include tests of people who were tested in the GGD test lanes and does not include any tests that are required in order to travel.
7 For more information about the reproduction number, click here.
8 The reproduction numbers (R) based on NICE data are calculated using hospital and ICU admissions due to COVID-19. These calculations do not include admissions registered by NICE after 25 January 2022 for any reason other than COVID-19.
9 Based on data available at RIVM on Monday afternoon, 16 May 2022, as published in the open data. See the sewage surveillance updates on the Coronavirus Dashboard for the latest figures. See the explanation of the data presented for more details about how these figures are calculated.
10 In the first half of last week, between 1 and 3 samples were taken from each sampling location and analysed. The samples were taken on the Monday, Tuesday and/or Wednesday of that week.
11 Ideally, a total of 4 sewage samples from all 312 sampling locations would be taken and analysed in order to calculate the average for the previous week.
12 Number of people connected to the number of sampling locations on which the average is based. 


11 May 2022 | 16:00

Repeat vaccination restores protection against hospital admission to level shortly after booster

In the period from 1 February 2022 to 3 May 2022, vaccine effectiveness of the repeat vaccination against COVID-19 in preventing hospital admission was 88%. In the same period, vaccine effectiveness in preventing hospital admission was 78% among people aged 70 years and older who had received the booster jab but not the repeat vaccination, and 37% among people who had only received the basic series of COVID-19 vaccinations.

Read more: Repeat vaccination restores protection against hospital admission to level shortly after booster

 


11 May 2022 | 8:30

Vaccination figures: 2 to 8 May 2022

Up to and including Sunday 8 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 38.9%.

Read more in the weekly update on COVID-19 vaccination figures.


10 May 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  3 May to 10 May 2022

ast week, the number of new hospital admissions of patients1 with SARS-CoV-2 decreased by 28% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 32%, compared to the week before. The number of newly reported COVID-19 tests decreased slightly (-6%) compared to the week before. 

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

10,0072

(55 per 100,000 inhabitants)

15,5963

(57 per 100,000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

259

 

211

362

 

287

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)4,5

21

 

18

31

 

20

Deaths6 19 28
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 18 week 17
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

15,466

8,258
53.3%

16,130

8,266
51,2%

     
Number of tests intended to confirm a positive self-test9
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test

6.587

5,844
88.7%

6.517
5.799
89,0%
     
Number of tests not intended to confirm a positive self-test10
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
5,932
1,102
18.6%
6,633
1,247
18.8%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

2,947

1,302

44.2%

2,980

1,220

40.9%

  Latest calculation One week before
Reproduction numbers11 On 25 April 2022 On 18 April 2022
Based on reported positive tests 0,95 (0,90 - 1,00) 0,72 (0,69 - 0,75)
Based on hospital admissions (Source: NICE)12 0,78 (0,49 - 1,11) 0,77 (0,54 - 1,04)
Based on ICU admissions (Source: NICE)12 0,82 (0,00 - 2,71) 0,82 (0,00 - 1,99)

03 May 2022 | 16:00

Vaccination figures: 25 April to 1 May 2022

Up to and including Sunday 1 May, more than 1.8 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 37.7%.

Read more in the weekly update on COVID-19 vaccination figures.


3 May 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2: 26 april to 3 May 2022

Last week, the number of new hospital admissions of patients1 with SARS-CoV-2 decreased by 40% and the number of new patients with SARS-CoV-2 in the ICU also decreased by 40%, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-34%) last week compared to the week before that.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

10.5962

(57 per 100.000 inhabitants)

16.0543

(88 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

315

 

249

522

 

435

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)4,5

30

 

21

50

 

42

Deaths6 28 66
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 17 week 16
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

16,130

8,266
51.2%

24,755

13,618
55.0%

     
Number of tests intended to confirm a positive self-test9
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test

6.517

5,799
89.0%

10,876
9,738
89,5%
     
Number of tests not intended to confirm a positive self-test10
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
6,633
1,247
18.8%
9,788
2,021
20.6%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

4,980

1,220

40.9%

4,091

1,859

45.4%

  Latest calculation One week before
Reproduction numbers11 On 18 April 2022 On 11 April 2022
Based on reported positive tests 0,72 (0,69 - 0,75) 0,64 (0,62 - 0,67)
Based on hospital admissions (Source: NICE)12 0,77 (0,54 - 1,04) 0,80 (0,59 - 1,03)
Based on ICU admissions (Source: NICE)12 0,82 (0,00 - 1,99) 0,92 (0,18 - 1,99)

26 April 2022 | 16:15

Protection from repeat vaccination remains effective against severe COVID-19

In the period from 1 February 2022 to 19 April 2022, vaccine effectiveness of the basic series of COVID-19 vaccinations in preventing hospital admission was 30%. After the booster jab, that percentage was 79%. 

Read the news: Protection from repeat vaccination remains effective against severe COVID-19


26 April 2022 | 16:00

Vaccination figures 18-24 April 2022

Up to and including Sunday 24 April, more than 1.7 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has now reached 35.8%.

Read more in the weekly update on COVID-19 vaccination figures.


26 April 2022 | 16:00 PM

Weekly update on the coronavirus SARS-CoV-2: 19 April to 26 april 2022

Last week, the number of new hospital admissions of patients1 with SARS-CoV-2 decreased by 35% and the number of new patients with SARS-CoV-2 in the ICU decreased by 29%, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-35%) last week compared to the week before that.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

16,0542

(88 per 100.000 inhabitants)

24,7073

(137 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

448

 

374

686

 

544

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)4,5

42

 

37

59

 

44

Deaths6 66 52
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 16 week 15
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*

24,755

13,618
55.0%

41,359

24,150
58.4%

     
Number of tests intended to confirm a positive self-test9
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
10,876
9,738
89.5%
18,719
17,058
91.1%
     
Number of tests not intended to confirm a positive self-test10
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
9,787
2,020
20.6%
15,774
3,777
23.9%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

4,092

1,860

45.5%

6,866

3,315

48.3%

  Latest calculation One week before
Reproduction numbers11 On 11 April 2022 On 31 March 2022**
Based on reported positive tests 0,64 (0,62 - 0,67) 0,71 (0,70 – 0,73)
Based on hospital admissions (Source: NICE)12 0,80 (0,59 - 1,03) 0,89 (0,71 – 1,08)
Based on ICU admissions (Source: NICE)12 0,92 (0,18 - 1,99) 1,02 (0,30 – 1,99)

19 April 2022 | 16:00

Vaccination figures 11-17 April 2022

Up to and including Sunday 17 April, more than 1.5 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 32.7%.

Read more in the weekly update on COVID-19 vaccination figures.


19 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2: 12 April to 19 april 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-21 decreased by 53%* and the number of new patients with SARS-CoV-2 in the ICU decreased by 31%*, compared to the week before. The number of newly reported positive COVID-19 tests was also lower (-63%) last week compared to the week before that. Since last Monday, 11 April 2022, positive self-tests no longer need to be confirmed by the Municipal Public Health Services (GGDs). As a result, the number of people who get a GGD test to confirm a positive self-test will decrease. This means that the number of positive COVID-19 tests cannot be fully compared to previous weeks.

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

24,7072

(137 per 100.000 inhabitants)

66,7883

(373 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

482*

 

378

1,017

 

827

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)4,5

50*

 

37

72

 

53

Deaths6 52 81
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 15 week 15
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**

41,359

24,150
58,4%

110,655

67,772
61.2%

     
Number of tests intended to confirm a positive self-test9
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
18,719
17,058
91.1%
52,561
48,733
92.7%
     
Number of tests not intended to confirm a positive self-test10
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
15,774
3,777
23.9%
43,573
11,428
26.2%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

6,866

3,315

48.3%

14,521

7,611

52.4%

  Latest calculation One week before
Reproduction numbers11 On 31 March 2022 On 28 March 2022
Based on reported positive tests 0,71 (0,70 – 0,73) 0,69 (0,68 – 0,70)
Based on hospital admissions (Source: NICE)12 0,89 (0,71 – 1,08) 0,80 (0,65 – 0,97)
Based on ICU admissions (Source: NICE)12 1,02 (0,30 – 1,99) 0,81 (0,18 – 1,63)

12 April 2022 | 16:00

Repeat vaccination effective in preventing severe COVID-19

In the period from 1 February 2022 to 5 April 2022, vaccine effectiveness of the basic series of COVID-19 vaccinations in preventing hospital admission was 35%. After the booster vaccination, that percentage was 81%. Vaccine effectiveness against ICU admission was 45% after the basic series, compared to 90% after booster vaccination. 

Read the news: Repeat vaccination effective in preventing severe COVID-19


12 April 2022 | 16:00

Vaccination figures 4-10 April 2022

Up to and including Sunday 10 April, more than 1.3 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19 three months after their last COVID-19 vaccination or three months after a SARS-CoV-2 infection. Vaccination coverage for the repeat vaccination among people over 60 has reached 28.5%.

Read more in the weekly update on COVID-19 vaccination figures.


12 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:   5 April to 12 april 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 decreased by 29%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 20%*. The number of newly reported positive COVID-19 tests was also lower (-48%) last week compared to the week before that. 

The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

66,7881

(373 per 100.000 inhabitants)

129,1882

(739 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

889

 

727

1,248

 

984

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

68

 

49

85

 

64

Deaths5 81 113
     
SARS-CoV-2 tests by the GGD per calendar week6,7 week 14 week 13
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**

110,655

67,773
61.2%

220,511

135,073
61.3%

     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
52,561
48,733
92.7%
161,646
94,991
93,5%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
43,573
11,428
26.2%
91,127
25,416
27.9%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

14,521

7,612

52.4%

27,738

14,666

52.9%

  Latest calculation One week before
Reproduction numbers9 On 28 March 2022 On 21 March 2022
Based on reported positive tests 0,69 (0,68 – 0,70) 0,79 (0,78 – 0,80)
Based on hospital admissions (Source: NICE)10 0,0,80 (0,65 – 0,97) 00,81 (0,67 – 0,95)
Based on ICU admissions (Source: NICE)9 0,81 (0,18 – 1,63) 0,86 (0,34 – 1,53)

5 April 2022 | 16:00

Vaccination figures: 28 March to 3 April 2022

Up to and including Sunday 3 April, more than 1 million repeat vaccinations had been administered. People aged 60 years and older, people living in nursing homes, and people with severely impaired immunity are eligible to get a repeat vaccination against COVID-19. They can get the repeat vaccination 3 months after their last COVID-19 vaccination or 3 months after a SARS-CoV-2 infection. As of this week, this report also includes vaccination coverage and the graph by age for the repeat vaccination against COVID-19. Vaccination coverage for the repeat vaccination among people over 60 has reached 22.4%.

Read more in the weekly update on COVID-19 vaccination figures


5 April 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  29 March to 5 April 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 in the Netherlands decreased by 32%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 35%*. The number of newly reported positive COVID-19 tests was also lower (-42%) last week compared to the week before that. The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

From Saturday, 9 April 2022, no data will be published on weekends and public holidays* (days off). This is in line with the current situation regarding the coronavirus SARS-CoV-2. RIVM continues to monitor the development of the virus closely.

*Public holidays on which data will not be reported: New Year’s Day, Easter Sunday and Easter Monday, King’s Day, Liberation Day, Ascension Day, Whit Sunday and Whit Monday, Christmas Day and Boxing Day (in 2022: Saturday 1 January, Sunday 17 and Monday 18 April, Wednesday 27 April, Thursday 5 May, Thursday 26 May, Sunday 5 June and Monday 6 June, Sunday 25 and Monday 26 December).
 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

129,1881

(739 per 100.000 inhabitants)

222,3662

(1,264 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

1,110

 

903

1,626

 

1,286

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

81

 

63

125

 

97

Deaths5 113 104
     
SARS-CoV-2 tests by the GGD per calendar week6,7 week 13 week 12
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**

220,512

135,073
61.3%

331,247

216,610
65.4%

     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
101,646
94,991
93.5%
161,107
152,047
94.4%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
91,127
25,416
27.9%
130,865
42,,387
32.4%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

27,739

14,666

52.9%

39,275

22,176

56.5%

  Latest calculation One week before
Reproduction numbers9 On 21 March 2022 On 14 March 2022
Based on reported positive tests 0,79 (0,78 – 0,80) 0,82 (0,81 – 0,83)
Based on hospital admissions (Source: NICE)10 0,81 (0,67 – 0,95) 0,88 (0,74 – 1,02)
Based on ICU admissions (Source: NICE)9 0,86 (0,34 – 1,53) 0,94 (0,42 – 1,58)

29 March 2022 | 16:40

Protection from COVID-19 booster remains high, but wanes slightly for everyone after 3 months

In the period from 1 February 2022 to 22 March 2022, when more than 99% of hospital admissions were caused by the Omicron variant, vaccine effectiveness of the basic series in preventing hospital admission was 45%. After the booster vaccination, that percentage was 82%. Vaccine effectiveness against ICU admission was 57% after the basic series, compared to 91% after booster vaccination. 

Read the news: Protection from COVID-19 booster remains high, but wanes slightly for everyone after 3 months


29 March 2022 | 16:15

Vaccination figures 21 to 27 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. As of 26 March, this option is available to people aged 60 years and older. Up to and including Sunday 27 March, more than 725,000 repeat vaccinations had been administered.

Read more in the weekly update on COVID-19 vaccination figures.  


Weekly update on the coronavirus SARS-CoV-2:  22 to 29 March 2022

Last week, the number of new hospital admissions of patients with SARS-CoV-2 decreased by 19%* compared to the week before, and the number of new patients with SARS-CoV-2 in the ICU decreased by 9%*. The number of newly reported positive COVID-19 tests was also lower (-29%) last week compared to the week before that. The reproduction number is below 1. See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

222,3661

(1,471 per 100.000 inhabitants)

313,3182

(1,785 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

1,471

 

1,195

1,825

 

1,450

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

118

 

92

129

 

102

Deaths5 104 95
     
SARS-CoV-2 tests by the GGD per calendar week6,7 week 12 week 11
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**

331,229

216,596
65.4%

452,934

299,654
66.2%

     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
161,095
152,037
94.4%
220,990
208,906
94.5%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
130,861
42,385
32.4%
181,758
61,982
34.1%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

39,273

22,174

56.5%

61,982

28,766

57.3%

  Latest calculation One week before
Reproduction numbers9 On 14 March 2022 On 7 March 2022
Based on reported positive tests 0,82 (0,81 – 0,83) 0,87 (0,86 – 0,88)
Based on hospital admissions (Source: NICE)10 0,88 (0,74 – 1,02) 0,96 (0,81 – 1,11)
Based on ICU admissions (Source: NICE)9 0,94 (0,42 – 1,58) 1,03 (0,45 – 1,74)

22 March 2022 | 16:30

Vaccination figures 14 to 20 March 2022

As of 4 March 2022, people aged 70 years and older, people living in nursing homes, and certain groups of people with impaired immunity can get a repeat vaccination against COVID-19. Up to and including Sunday 20 March, 429,000 repeat vaccinations had been administered. 

Numbers and vaccination coverage for the basic series

By Sunday 20 March 2022, it is estimated that nearly 25 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Read more in the weekly update on COVID-19 vaccination figures.  


22 March 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  15 to 22 March 2022

Last week, there was a 7%* decrease in the number of new hospital admissions of patients with SARS-CoV-2. 15% more new COVID-19 patients were admitted to ICU compared to the week before*. The number of newly reported positive COVID-19 tests decreased by 27% last week compared to the week before that. Reported figures decreased in most age groups. The number of reported positive tests remained stable over the course of the week among people aged 70 years and older. However, even in that age group, the daily number of reported positive tests decreased during the week. The reproduction number is below 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays. Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

313,3181

(1,785 per 100.000 inhabitants)

429,2522

(2,451 per 100.000 inhabitants)

Total new hospital admissions of patients with SARS-COV-2 (including ICU admissions)3

New hospital admissions of patients with SARS-CoV-2 (including ICU admissions) not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

1,616

 

1,291

1,742

 

1,327

Total new ICU admissions of patients with SARS-CoV-23

New ICU admissions not including patients with an admission reason other than SARS-CoV-2  (Source: NICE)3,4

114

 

91

99

 

77

Deaths5 95 104
     
SARS-CoV-2 tests by the GGD per calendar week6,7 week 11 week 10
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**

452,936

299,654
66.2%

625,710

414,245
66.2%

     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
220,987
208,891
94.5%
304,322
286.467
94.1%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
181,763
61,995
34.1%
258,454
91,533
35.4%
     

Number of tests for which it is unknown whether it was a confirmation test8
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

50,186

28,768

57.3%

62,934

36,245

57.6%

  Latest calculation One week before
Reproduction numbers9 On 7 March 2022 On 28 February 2022
Based on reported positive tests 0,87 (0,86 – 0,88) 1,27 (1,26 – 1,28)
Based on hospital admissions (Source: NICE)10 0,96 (0,81 – 1,11) 1,08 (0,92 – 1,26)
Based on ICU admissions (Source: NICE)9 1,03 (0,45 – 1,74) 1,04 (0,40 – 1,81)

15 March 2022 | 16:57 PM

Vaccination figures 7 to 13 March 2022

Numbers and vaccination coverage for the basic series

By Sunday 13 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series

Read more in the weekly update on COVID-19 vaccination figures


15 March 2022 | 16:45 PM

Weekly update on the coronavirus SARS-CoV-2:  8 march to 15 March 2022

Last week, there was a 14% increase in the number of new hospital admissions of patients with SARS-CoV-2. 6% more new COVID-19 patients were admitted to ICU compared to the week before. In the Netherlands as a whole, the number of newly reported positive COVID-19 tests remained fairly stable (-2%) compared to the week before that. Reported figures increased in 15 of the 25 GGD regions. In the Carnival regions, which had reported the biggest increase two weeks ago, the number of newly reported positive tests decreased in the past week. The daily number of positive tests decreased or stabilised during the past week, at national and regional levels. In most age groups, there was a slower increase in reported positive tests compared to the previous week. The number of reported positive tests continued to rise sharply among older people: 66% in the age group of 60-69 years, 104% in the age group of 70-79 years, and 102% among people over 80. Although the number of reported positive tests had remained stable two weeks ago among children aged 0-12 years, the number of reported positive tests in that age group increased by 33% last week. This may be due to increased testing after the holidays. The reproduction number is above 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays. Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

429,2521

(1,545 per 100.000 inhabitants)

439,7752

(1,356 per 100.000 inhabitants)

New hospital admissions (Source: NICE)3 1,545 1,356
Of which new ICU admissions (Source: NICE)3 91 86
Deaths4 104 56
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 10 week 9
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
625,649
414,212
66.2%
597,192
417,867
70.0%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
304,284
286,438
94.1%
308,460
292.904
95.0%
     
Number of tests not intended to confirm a positive self-test7
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
258,437
91,532
35.4%
234,190
92,099
39.3%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

62,928

36,242

57.6%

54,542

32,864

60.3%

  Latest calculation One week before
Reproduction numbers8 On 28 February On 21 February
Based on reported positive tests 1,27 (1,26 – 1,28) 1,00 (0,99 – 1,02)
Based on hospital admissions (Source: NICE)9 1,08 (0,92 – 1,26) 0,97 (0,80 – 1,15)
Based on ICU admissions (Source: NICE)9 1,04 (0,40 – 1,81) 0,94 (0,34 – 1,69)

 


8 March 2022 | 16:30 PM

Vaccination figures 28 February 2022 to 6 March 2022

Numbers and vaccination coverage for the basic series

By Sunday 6 March 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 133,000 third vaccinations were administered to people with severely impaired immunity.

It is estimated that 86.4% of all people over 18 have now completed the basic series. According to estimates, 84.9% of all people over 12 years old have completed the basic series.

Read more in the weekly update on COVID-19 vaccination figures


8 March 2022 | 16:15 PM

Weekly update on the coronavirus SARS-CoV-2:  1 march to 8 March 2022

Significant increase in positive COVID-19 tests, rising highest in Carnival regions

After several weeks of decreasing figures in the Netherlands, the number of people who tested positive for SARS-CoV-2 in the past week rose to 439,775, from 245,898 a week before (+79%). 
This significant increase is a combined effect of the Carnival week and the relaxed measures. Reported figures increased in all regions. In various areas in the provinces of Noord-Brabant and Limburg, reported positive tests per 100,000 inhabitants reached the highest point yet. Reported positive tests also increased in other regions, but less sharply, and the weekly number of reported positive tests did not exceed the levels observed during the Omicron wave in January and February 2022. The number of people who were tested by the Municipal Public Health Services (GGDs) increased by +60%, rising to 594,865 tests. At the GGD test sites in Noord-Brabant and Limburg, the waiting time to get tested is currently longer than usual. 

Kaart van het aantal meldingen per 100.000 inwoners in de afgelopen week (1 maart tot en met 8 maart 2022) per gemeente.

Figure 1: Map of newly reported positive COVID-19 tests per 100,000 inhabitants in the past week (1 March to 8 March 2022) by municipality. 

The number of reported positive tests stabilised in the age group of 0-12 years. In all other age groups, the number of reported positive tests increased, doubling in the age groups of 18 to 24 years (+111%) and 25 to 29 years (+99%). Another striking trend this week is the major increase in the number of positive tests among people aged 60 years and over compared to a week before. During the Omicron wave in the first two months of this year, infections among this age group in particular remained stable and low compared to the large number of infections among younger age groups.

Last week, the number of new hospital admissions of patients with SARS-CoV-2 stabilised compared to the week before, and there were 16% fewer new patients in the ICU than in the week before that. On average, the impact of a rising infection rate on the number of hospital admissions becomes apparent about two weeks later. Because vulnerable people and older people have a higher risk of hospital admission after infection with the coronavirus SARS-CoV-2, they are strongly advised to take additional precautions to protect themselves (see Recommendations for vulnerable groups | RIVM.nl) and to get the booster vaccination or repeat booster against COVID-19.

All the weekly COVID-19 figures are presented in a table and in graphs on the RIVM website and in the weekly epidemiological update. A great deal of information can also be found on the Coronavirus Dashboard.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

439,7751

(2.517 per 100.000 inhabitants)

245,8982

(1.408 per 100.000 inhabitants)

New hospital admissions (Source: NICE)3 1,171 1,118
Of which new ICU admissions (Source: NICE)3 82 98
Deaths4 56     63
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 9 week 8
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
594,865
416,141
70.0%
372,354
233,193
62.6%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
307,146
291,637
95.0%
175,522
164,184
93.5%
     
Number of tests not intended to confirm a positive self-test7
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
233,333
91,748
39.3%
166,809
53,670
32.2%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

54,386

32,756

60.2%

30,023

15,339

51.1%

  Latest calculation One week before
Reproduction numbers8 On 21 February On 14 February
Based on reported positive tests 1,00 (0,99 – 1,02) 0,77 (0,76 – 0,78)
Based on hospital admissions (Source: NICE)9 0,97 (0,80 – 1,15) 0,95 (0,80 – 1,12)
Based on ICU admissions (Source: NICE)9 0,94 (0,34 – 1,69) 0,98 (0,41 – 1,69)

2 March 2022 | 9:15

Booster vaccination offers effective protection against hospital and ICU admission due to COVID-19

From 1 December 2021 to 22 February 2022, vaccine effectiveness for the COVID-19 booster vaccination was 94% against hospital admission and 98% against ICU admission.

Read the news: Booster vaccination offers effective protection against hospital and ICU admission due to COVID-19


1 March 2022 | 16:00 

Vaccination figures 21 to 27 February 2021

Number of vaccinations in the basic series

By Sunday 27 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. About 13.5 million of those were first vaccinations, and nearly 11.5 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures


1 March 2022 | 15:00 PM

Weekly update on the coronavirus SARS-CoV-2:  22 February to 1 March 2022

Last week, there were 26% fewer new hospital admissions and 15% fewer new ICU admissions of patients with SARS-CoV-2 compared to the week before. The number of newly reported positive COVID-19 tests decreased by 21% last week compared to the week before that. The reproduction number is below 1.

See the Coronavirus Dashboard for graphs and information on the SARS-CoV-2 situation. Information on the SARS-CoV-2 situation in the Netherlands can also be found on the graphs page and in the epidemiological report, which is updated every week on Tuesdays.  Much of the data used to keep track of the SARS-CoV-2 figures is available to the public. These open data files are published every day at 15:15.

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Number of newly reported positive tests (by date as published by RIVM)

245,8981

(1,408 per 100,000 inhabitants)

310,1442

(1,764 per 100,000 inhabitants)

New hospital admissions (Source: NICE)3 998 1,349
Of which new ICU admissions (Source: NICE)3 88 104
Deaths4 63 95
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 8 week 7
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
372,349
233,192
62.6%
519,494
302,859
58.3%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
175,520
164,184
93.5%
225,919
207,249
91.7%
     
Number of tests not intended to confirm a positive self-test7
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
166,806
53,669
32.1%
254.320
76,568
30.1%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

30,023

15,339

51,1%

39,255

19,042

48.5%

  Latest calculation One week before
Reproduction numbers8 On 14 February On 7 February
Based on reported positive tests 0,77 (0,76 – 0,78) 0,83 (0,82 – 0,84)
Based on hospital admissions (Source: NICE)9 0,95 (0,80 – 1,12) 0,99 (0,84 – 1,16)
Based on ICU admissions (Source: NICE)9 0,98 (0,41 – 1,69) 1,01 (0,45– 1,73)

22 February 2022 | 16:00

Vaccination figures 14 to 20 February 2021

Number of vaccinations in the basic series

By Sunday 20 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  More than 133,000 third vaccinations were administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures


22 February 2022 | 16:10 PM

Weekly update on the coronavirus SARS-CoV-2:  15 February to 22 February 2022

Read the news: Decrease in SARS-CoV-2 hospital admissions, fewer people tested 

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported positive tests (by date as published by RIVM)*

310,1441

(1,764 per 100,000 inhabitants)

493,0552

(2,791 per 100,000 inhabitants)

New hospital admissions (Source: NICE)3 1,214 1,381
Of which new ICU admissions (Source: NICE)3 97 95
Deaths4 95 78
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 7 week 6
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
519,444
302,822
58.3%
833.269
480,093
57.6%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
225,884
207,218
91.7%
351,526
319,488
90.9%
     
Number of tests not intended to confirm a positive self-test7
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
254,308
76,564
30.1%
413,807
127,317
30.8%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

39.,52

19,040

48.5%

67,936

33,288

49.0%

  Latest calculation One week before
Reproduction numbers8 On 7 February On 31 January
Based on reported positive tests 0,83 (0,82 – 0,84) 0,98 (0,97 – 0,99)
Based on hospital admissions (Source: NICE)9 0,99 (0,84 – 1,16) 0,97 (0,81 – 1,14)
Based on ICU admissions (Source: NICE)9 1,01 (0,45– 1,73) 0,94 (0,39 – 1,63)

1

 

5 February 2022 | 17:20

Booster vaccination prevents many hospital and ICU admissions

In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations. During this period, the vast majority of hospital admissions were caused by the Omicron variant of the coronavirus SARS-CoV-2. 

Read the news: Booster vaccination prevents many hospital and ICU admissions


15 February 2022 | 17:00

Vaccination figures 7 to 13 February 2021

Number of vaccinations in the basic series

By Sunday 13 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity.

Read more in the Weekly update on COVID-19 vaccination figures


15 February 2022 | 16:50 PM

Weekly update on the coronavirus SARS-CoV-2:  8 February to 15 February 2022

Read the news: Omicron subvariant BA.2 becomes dominant, decrease in hospital admissions

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported positive tests (by date as published by RIVMNational Institute for Public Health and the Environment)* 493,0551 824,3042
Newly reported positive tests (by date of positive test result)

482,6953

(2,762 per 100,000 inhabitants)

616,3954

(3,527 per 100,000 inhabitants)

New hospital admissions (Source: NICE)5 1,149 1,393
Of which new ICU admissions (Source: NICE)5 88 122
Deaths6 78 54
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 6 week 5
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**
833,178
480,038
57,6%
977,734
593,316
60.7%
     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
351,486
308,698
90.9%
425,289
388,533
91.4%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
413,753
127,288
30.8%
447,746
149,664
33.4%
     

Number of tests for which it is unknown whether it was a confirmation test9
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

67,939

33,291

49.0%

104,699

55,119

52.6%

  Latest calculation One week before
Reproduction numbers10 On 31 January On 24 January
Based on reported positive tests 0.98 (0.97 – 0.99) 1.11 (1.10 – 1.11)
Based on hospital admissions (Source: NICE) 0.97 (0.81 – 1.14) 1.08 (0.91 – 1.27)****
Based on ICU admissions (Source: NICE) 0.94 (0.39 – 1.63) 1.13 (0.49 – 1.99)****

8 February 2022 | 19:45 PM

Weekly update on the coronavirus SARS-CoV-2:  1 February to 8 February 2022

Read the news: Increase in COVID-19 hospital admissions, positive tests reaching high plateau

  Last week Two weeks ago
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections (by date as published by RIVMNational Institute for Public Health and the Environment)* 824,3041 539,0152
Newly reported COVID-19 infections (by date of positive test result)

608,5293

(3,399 per 100,000 inhabitants)

594,0604

(3,482 per 100,000 inhabitants)

New hospital admissions (Source NICE)5 1,266 1,185
Of which new ICU admissions (Source: NICE)5 118 83
Deaths6 54 66
     
SARS-CoV-2 tests by the GGD per calendar week7,8 week 5 week 4
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**
977,564
593,220
60,7%
1,019,986
572,229
56.1%
     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
425,216
388,476
91.4%
370,480
337,479
91.1%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
447,682
149,640
33.4%
518,329
168,899
32.6%%
     

Number of tests for which it is unknown whether it was a confirmation test9
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

104,666

55,104

52.6%

131,177

65,751

50.1%

  Latest calculation One week before
Reproduction numbers10 On 24 January On 17 January
Based on reported positieve tests**** 1.11 (1.10 – 1.11) 1.20 (1.19 – 1.21)
  On 22 January11 On 15 January
Based on hospital admissions (Source: NICE) 1.08 (0.91 – 1.27) 1.12 (0.93 – 1.31)
Based on ICU admissions (Source: NICE) 1.13 (0.49 – 1.99) 1.08 (0.45 – 1.81)

8 February 2022 | 16:00

Vaccination figures: 31 January 2022 to 6 February 2022

Number of vaccinations in the basic series

By Sunday 6 February 2022, it is estimated that more than 24.9 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  About 133,000 third vaccinations have been administered to people with severely impaired immunity. 

Read more in the Weekly update on COVID-19 vaccination figures


8 February 2022 | 14:00

Slight delay in weekly update on reported positive tests

The weekly update on positive tests and hospital admissions that RIVM normally posts on Tuesday around 15:00 hrs, and the accompanying open data, will be published later today. 

The number of reported positive COVID-19 tests rose dramatically over the past few weeks. Due to the high volume of positive test results, the Municipal Public Health Services (GGDs) has experienced delays in transmitting these figures to RIVM since 18 January 2022. As a result, the actual number of reported positive tests was higher than the numbers reported daily by RIVM. The reported positive tests from the GGD test lanes were first entered into a GGD system. From there, the reported positive test results were transferred to a second GGD system, where information from source and contact tracing was entered by hand. As of today, reported figures on positive tests will be sent directly from the GGD test lanes to RIVM; this includes the new reported positive tests and the previous positive tests that were not yet reported to RIVM. As a result of this catch-up action, RIVM will be reporting a particularly high number of positive tests today. Today’s weekly news item on COVID-19 figures will be delayed slightly, and is expected to be published between 16:00 and 16:30 hrs.


1 February 2022 | 19:00

Booster vaccination still very effective

From 1 December 2021 to 25 January 2022, vaccine effectiveness for the COVID-19 booster vaccination was 97% against hospital admission and 98% against ICU admission.

A booster vaccination provides more protection against hospital admission than only completing the basic series of COVID-19 vaccinations: 97% compared to 83%. This means that the risk of hospital admission after a booster vaccination is 33 times lower compared to no COVID-19 vaccinations and 5 times lower compared to a completed basic series without a booster. 

Read more about Booster vaccination still very effective


1 February 2022 | 16:00

Vaccination figures: 24 to 30 January 2022 

Number of vaccinations in the basic series

By Sunday 30 January 2022, it is estimated that more than 24.8 million first and second vaccinations in the basic series of COVID-19 vaccinations had been administered in the Netherlands. More than 13.4 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  Nearly 133,000 third vaccinations have been administered to people with severely impaired immunity.  

Read more in the Weekly update on COVID-19 vaccination figures


1 February 2022 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  25 January to 1 February 2022

Read the news: Over half a million positive COVID-19 tests, more hospital admissions

  Last week1 Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections*

530,015

(2,817 per 100,000 inhabitants)

366,120

(2,034 per 100,000 inhabitants)

New hospital admissions (Source NICE)3 1,056 951
Of which new ICU admissions (Source: NICE)3 78 66
Deaths4 66 61
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 4 week 3
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**
1,019,496
571,920
56.1%
950,160
431,659
45.4%
     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
370,252
305,196
91.1%
241,851
218,344
90.3%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
518,109
168,816
32.6%
566,320
152,968
27.0%%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

131,135

65,730

50.1%

141,989

60,347

42.5%

  Latest calculation One week before
Reproduction numbers8 On 17 January On 10 January
Based on reported infections 1.20 (1.19 – 1.21) 1.19 (1.18 – 1.20)
  On 15 January**** On 18 January
Based on hospital admissions (Source: NICE) 1.12 (0.93 – 1.31) 0.99 (0.80 – 1.19)
Based on ICU admissions (Source: NICE) 1.08 (0.45 – 1.81) 0.85 (0.38 – 1.44)

28 January 2022 | 17:45

Update on backlog in positive COVID-19 tests

The backlog in the daily number of reported positive COVID-19 tests is currently about 72,000. This is due to the current high numbers of positive tests. All positive test results are entered into a system by the Municipal Public Health Services (GGDs). From that GGD system, the reported positive test results are then transferred to a second GGD system, where information from source and contact tracing is entered by hand. Due to the high volume of reported positive tests, entering this information takes a lot of work. Many aspects of this process have already been automated by the GGD recently, but the technical solution is not yet working optimally. As a result, there is a delay in sending the data from the GGD to RIVMNational Institute for Public Health and the Environment.

They are working to resolve the delay. It is expected to be resolved next week.


25 January 2022 | 16:45

Vaccination figures: 17 to 23 January 2022 

As of this week, the COVID-19 updates also include the number of vaccinations in the basic series and the number of booster vaccinations. In addition to vaccination coverage for the basic series, this update now also includes booster vaccination coverage by age group. 

Read more in the Weekly update on COVID-19 vaccination figures


25 January 2022 | 4:00 PM

Weekly update on the coronavirus SARS-CoV-2:  18 January to 25 January 2022

The number of reported positive COVID-19 tests increased by 51% last week compared to the week before that, rising to 366,120. Since 18 January 2022, an estimated 60,000 positive COVID-19 tests have not yet been reported to RIVMNational Institute for Public Health and the Environment as a result of the huge volume of positive test results at the Municipal Public Health Services (GGDs).* Based on the positive tests reported to RIVM in the past week, the biggest increase in reported positive tests  per 100,000 inhabitants was seen among children and adolescents in the primary school (+161%) and secondary school (+112%) age groups. There was also a clear increase in the number of positive COVID-19 tests among people in their thirties (+42%) and forties (+42%). The number of positive COVID-19 tests decreased in the age group of 18-24 years (-13%) (see Figure 1).The other age groups showed relatively minor differences from one week to the next. The number of people who were tested by the GGD increased by 37 in the past calendar week, compared to the week before that. After a period in which figures decreased, hospital admissions rose again in the past week. 855* new hospital admissions were reported last week, an increase of +15% compared to the week before that. This seems to mark a trend shift, with hospital admissions moving into an upward trend again. 65 new patients were admitted to ICU last week, a decrease of 34% compared to the week before that. The reproduction number based on the number of positive COVID-19 tests reported to RIVM* is still well below 1. 

Graph Number of reported positive tests per 100,000 inhabitants, by age group week 3 2022

* There is currently a backlog in the daily number of positive COVID-19 tests reported by RIVMNational Institute for Public Health and the Environment, compared to the actual figures reported by the Municipal Public Health Services (GGD). Numbers are currently so high that it is causing delays in sending the figures from the GGD system to RIVM. These figures do not include about 60,000 positive tests that were reported between 18 and 25 January 2022. A technical solution is being developed to catch up and eliminate this backlog, but it will take some time. The reproduction number based on reported infections may temporarily be too low due to the backlog, which will be corrected when the delayed reports have been incorporated.

** The NICE Foundation and the hospitals cannot yet distinguish between the number of patients who were admitted due to COVID-19 and the number of patients admitted to hospital who tested positive for SARS-CoV-2, but were admitted for another reason. They are working on a solution for that.

  Last week1 Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections*

366,120

(2,034 per 100,000 inhabitants)

242,961

(1,380 per 100,000 inhabitants)

New hospital admissions (Source NICE)3 855 741
Of which new ICU admissions (Source: NICE)3 65 99
Deaths4 61 63
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 3 week 2
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**
949,034
431,549
45.4%
695,512
256,115
36.8%
     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
241.779
218,286
90.3%
137.306
120.778
88.0%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
566,223
152,932
27.0%
451,249
98.780
21.9%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

141,932

60,331

42.5%

106,957

36,557

34.1%

  Latest calculation One week before
Reproduction numbers8 On 10 January On 3 January
Based on reported infections 1,19 (1,18 – 1,20) 1,16 (1,14 – 1,17)
  On 8 January**** On 1 January
Based on hospital admissions (Source: NICE) 0,99 (0,80 – 1,19) 0,95 (0,77 – 1,14)
Based on ICU admissions (Source: NICE) 0,85 (0,38 – 1,44) 0,92 (0,50 – 1,44)

25 January 2022 | 11:15 AM

Shorter serial interval for Omicron variant

The Omicron variant of the coronavirus SARS-CoV-2 spreads faster than the Delta variant. Researchers from RIVM conclude in a preprint article that this faster spread can be attributed at least partly to the fact that the Omicron variant appears to have a shorter serial interval. This is the time between the first day of illness for the source contact and the first day of illness for the person they infect. The researchers reached this conclusion by looking at infections within households. On a PCR test, the Omicron variant shows S-gene target failure (SGTF, also known as ‘S-dropout’) while the Delta variant does not. Researchers looked at the serial interval of households where S-dropout did or did not occur. The serial interval was 3.4 days in households that showed S-dropout on the PCR tests, and 3.9 days in households without S-dropout. That means that the serial interval is a half-day shorter for the Omicron variant compared to the Delta variant.

More information: Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021 | medRxiv


20 January 2022 | 17:00 hrs

Backlog in figures for reported number of COVID-19 cases

There is currently a significant backlog in the daily number of positive COVID-19 tests reported by RIVM, compared to the actual figures reported by the Municipal Health Services (GGD). Numbers are currently so high that it is causing delays in transferring the figures from the GGD system to RIVM. The figures therefore do not yet include about 27,000 positive tests that were reported over the past three days. A technical solution is being developed to catch up and eliminate this backlog, but it will take some time. Therefore, the weekly RIVM update is currently the best way to monitor the course of the epidemic.


19 January 2022 | 4:00 PM

Booster vaccination very effective in preventing severe COVID-19

After a booster vaccination, the chance that a person infected with the coronavirus SARS-CoV-2 would be admitted to hospital was 33 times lower than for an unvaccinated person, and 5 times lower than for a person who had completed the basic series without a booster. The chance of ICU admission was 50 times lower after a booster compared to someone who is unvaccinated, and 4 times lower than for someone who had completed the basic series without a booster.* 

Effectiveness of booster vaccination in preventing hospital and ICU admission 

The booster vaccination campaign in the Netherlands started on 18 November 2021. For the first time, RIVM can now provide an update on the effectiveness of booster vaccination in preventing hospital and ICU admission. From 19 November 2021 to 13 January 2022, vaccine effectiveness for people who had received a booster vaccination was 97% against hospital admission and 98% against ICU admission. 

Read more about Booster vaccination very effective in preventing severe COVID-19


18 January 2022 | 4:00 PM

Vaccination figures: 10 to 16 January 2022 

By Sunday 16 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures


18 January 2022 | 3:50 PM

Weekly update on the coronavirus SARS-CoV-2:  11 January to 18 January 2022

Read the news: Nearly a quarter-million positive COVID-19 tests last week

  Last week1 Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections*

242,961

(1,380 per 100,000 inhabitants)

201,536

(1,147per 100,000 inhabitants)

New hospital admissions (Source NICE)3 647 940
Of which new ICU admissions (Source: NICE)3 94 146
Deaths4 63 116
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 2 week 1
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests**
695,378
256,035
36.8%
589,657
201,388
34.2%
     
Number of tests intended to confirm a positive self-test***
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
137,264
120,740
88.0%
102,171
90,240
88.3%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
451,160
98,739
21.9%
390,425
80,791
20.7%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

106,954

36,556

34.2%

97,061

30,357

31.2%

  Latest calculation One week before
Reproduction numbers8 On 3 January On 27 December
Based on reported infections 1,16 (1,14 – 1,17) 1,26 (1,24 – 1,28)
  On 1 January**** On 25 December
Based on hospital admissions (Source: NICE) 0,95 (0,77 – 1,14) 0,95 (0,78 – 1,12)
Based on ICU admissions (Source: NICE) 0,92 (0,50 – 1,44) 0,92 (0,53 – 1,38)

15 January 2022 | 09:00 AM

Advisory report of 138th OMT

On 12 January 2022, the Outbreak Management Team (OMT) convened to consult on the COVID-19 epidemic. Among other topics, the OMT discussed the following during this meeting:

  • the latest epidemiologcal data on the coronavirus SARS-CoV-2;
  • the expected course of the epidemic;
  • the projected consequences of any relaxations in measures taken to prevent the spread of the virus;
  • the use of face masks that cover the mouth and nose in public spaces;
  • a change in the quarantine rules, allowing workers in crucial & vital professions to leave quarantine for work (after a negative self-test).

Read more in the advisory report of the 138th OMT  (in Dutch).


11 January 2022 | 4:15 PM

Vaccination figures: 3 to 9 January 2022 

By Sunday 9 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures


11 January 2022 | 3:50 PM

Weekly update on the coronavirus SARS-CoV-2:  4 January to 11 January 2022

Read the news: 200 thousand people tested positive in one week

  Last week1 Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections*

201,536

(1,147 per 100,000 inhabitants)

113,554

(639 per 100,000 inhabitants)

New hospital admissions (Source NICE)3 873 1,046
Of which new ICU admissions (Source: NICE)3 143 171
Deaths4 116 189
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 1 week 52
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
589,564
201,353
34.2%
354,386
109,226
30.8%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
102,141
90,220
88.3%
57,238
50,657
88.5%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
390,373
80,779
20.7%
238,898
42,335
17.7%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

97,050

30,354

31.3%

58,250

16,234

27.9%

  Latest calculation One week before
Reproduction numbers8 On 27 December On 20 December
Based on reported infections 1.26 (1.24 – 1.28) 1.02 (1.00 – 1.03)
  On 25 December*** On 18 December
Based on hospital admissions (Source: NICE) 0.95 (0.78 – 1.12) 0.95 (0.80 – 1.11)
Based on ICU admissions (Source: NICE) 0.92 (0.53 – 1.38) 0.95 (0.58 – 1.37)

 


10 January 2022  | 21:19 PM

OMT advisory report, 7 January 2022

On 7 January 2022, the Outbreak Management Team (OMT) convened to consult on the COVID-19 outbreak. The OMT studied the latest epidemiological data on the coronavirus SARS-CoV-2 and issued an advisory report on the use of face masks that cover the mouth and nose. 

Read more in the advisory report of the 137th OMT (in Dutch). More information on the OMT can be found on the RIVM page about the Outbreak Management Team.


4 January 2022 | 4:15 PM

Weekly update on the coronavirus SARS-CoV-2:  28 December 2021 to 4 January 2022

Read the news: Omicron causes 35% increase in positive COVID-19 tests, despite lockdown

  Last week1 Two weeks ago2
Reports of people tested for SARS-CoV-2 who had a positive test result    
Newly reported COVID-19 infections*

113,554

(639 per 100,000 inhabitants)

84,398

(482 per 100,000 inhabitants)

New hospital admissions (Source NICE)3 981 1,137
Of which new ICU admissions (Source: NICE)3 164 196
Deaths4 189 272
     
SARS-CoV-2 tests by the GGD per calendar week5,6 week 52 week 51
Total number of tests of which results are known
Number of positive tests
Percentage of positive tests*
354,335
109,210
30.8%
346,722
81,000
23.4%
     
Number of tests intended to confirm a positive self-test**
Number of positive tests after a positive self-test
Percentage of positive tests after a positive self-test
57,230
50,650
88.5%
46,936
39,674
84.5%
     
Number of tests not intended to confirm a positive self-test
Number of positive tests not after a positive self-test
Percentage of positive tests not after a positive self-test
238,871
42,328
17.7%
240,155
28,739
12.0%
     

Number of tests for which it is unknown whether it was a confirmation test7
Number of positive tests for which it is unknown whether it was a confirmation test
Percentage of positive tests for which it is unknown whether it was a confirmation test

58,234

16,232

27.9%

59,631

12,587

21.1%

  Latest calculation One week before
Reproduction numbers8 On 20 December On 13 December
Based on reported infections 1.02 (1.00 – 1.03) 0.90 (0.89 – 0.92)
  On 18 December*** On 11 December
Based on hospital admissions (Source: NICE) 0.95 (0.80 – 1.11) 0.90 (0.77 – 1.04)
Based on ICU admissions (Source: NICE) 0.95 (0.58 – 1.37) 0.88 (0.56 – 1.25)

4 January 2022| 4:00 PM

Vaccination figures: 27 December 2021 - 2 January 2022

By Sunday 2 January 2022, it is estimated that more than 24.7 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and nearly 11.4 million were second vaccinations.  

Read more about COVID-19 vaccination figures